# Trialbench > Compare clinical trial software by features, study needs and published sources: ePRO, eCOA, eConsent, EDC, CTMS, RTSM, eTMF, patient registries and wearable data. ## Software guides Products are not ranked. Table order is chosen separately for each guide and is not a recommendation. - [Best CTMS software for research sites](https://bestclinicaltrialsoftware.com/best/ctms-software/): Research sites, site networks, hospitals and academic medical centers choosing a CTMS to run their own studies, participant visits and site finances. Sponsor and CRO CTMS products are out of scope. - [Advarra OnCore](https://bestclinicaltrialsoftware.com/software/advarra-oncore/): Academic medical centers, NCI-designated cancer centers and health systems running 50 to 500+ active trials on Epic or Cerner. - Study, participant and visit tracking: OnCore builds protocol calendars and automatic subject calendars for visit tracking and integrates with Epic, but public material does not describe recruitment or pre-screening tools. — source: https://www.mcw.edu/departments/research-systems/oncore/features — checked 2026-11-10 - Site finances: OnCore covers budget creation and negotiation, automated invoicing and payment reconciliation, and records billing designations per visit or procedure with a qualifying clinical trial checklist. — source: https://www.mcw.edu/departments/research-systems/oncore/features — checked 2026-11-10 - Connected site tools and integrations: Advarra lists Epic and Cerner integration, its Part 11-compliant eReg and EDC, eIRB via API and Advarra Payments as OnCore integrations. — source: https://www.advarra.com/oncore/ — checked 2026-11-10 - Proven fit and adoption: A January 2026 University of Arkansas for Medical Sciences release says OnCore is used by 80% of NCI-designated cancer centers. — source: https://news.uams.edu/2026/01/07/uams-winthrop-p-rockefeller-cancer-institute-expands-oncore-to-strengthen-clinical-trials/ — checked 2026-11-10 - Compliance and security: Advarra states its cloud-based technology holds ISO 27001:2013 and SOC 2 Type 2 certification, but it claims Part 11 for its eReg and EDC rather than the CTMS and makes no HIPAA statement for OnCore. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - Published pricing and terms: Advarra describes the pricing model (an annual subscription priced on licensed modules and protocol volume) but publishes no prices. — source: https://www.advarra.com/oncore/ — checked 2026-11-10 - [Advarra Clinical Conductor](https://bestclinicaltrialsoftware.com/software/advarra-clinical-conductor/): Site networks, hospitals and independent research sites that run research as a business and need finances across several sites. - Study, participant and visit tracking: Clinical Conductor supports scheduling, check-in and check-out, staff calendars and capacity planning across sites, plus participant outreach by text, email and phone. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - Site finances: It centralizes billing across sites, reconciles visit and non-visit revenue, shows gaps between expected and realized revenue and pays participants through CCPay, and Advarra lists an EMR billing-grid integration. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - Connected site tools and integrations: Advarra lists integrated eReg and eSource + EDC, EMR integrations (billing grid, demographics, subject and protocol data), Advarra Payments and a general-ledger link, and runs an API partner program for its CTMS products. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - Proven fit and adoption: Advarra says its CTMS products are used by more than 300 site networks, but gives no count for Clinical Conductor alone. — source: https://www.advarra.com/news/advancing-cancer-research-together-advarra-named-preferred-irb-and-ibc-partner-for-scris-late-stage-trials/ — checked 2026-11-10 - Compliance and security: Advarra states its cloud-based technology holds ISO 27001:2013 and SOC 2 Type 2 certification, but claims Part 11 only for the linked eReg and eSource products and HIPAA only for the CCText module. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - Published pricing and terms: Advarra publishes no Clinical Conductor prices or pricing model. — source: https://www.advarra.com/solutions/sites/ctms/clinical-conductor/ — checked 2026-11-10 - [CRIO Site CTMS](https://bestclinicaltrialsoftware.com/software/crio/): Independent sites and site networks that run most studies on eSource and want CTMS in the same system. - Study, participant and visit tracking: CRIO's Site CTMS combines a patient database with feasibility searches, phone screenings, pre-screening visits and scheduling that flows straight into eSource. — source: https://clinicalresearch.io/products/site-ctms/ — checked 2026-11-10 - Site finances: It sets visit- and procedure-level receivables, generates and tracks invoices, reconciles sponsor payments, supports GAAP reporting and pays patient stipends, but describes no research billing compliance features. — source: https://clinicalresearch.io/products/site-ctms/ — checked 2026-11-10 - Connected site tools and integrations: CRIO combines its own eSource, eConsent, eRegulatory and CTMS and integrates with Veeva Vault EDC and Medidata Rave, but documents no EHR integration or public API. — source: https://www.clinicalresearch.io/ — checked 2026-11-10 - Proven fit and adoption: CRIO's 2025 security white paper reports 2,500 sites, 6,000 protocols and 5 million patients in 30 countries. — source: https://clinicalresearch.io/wp-content/uploads/2025/09/Trust-Without-Compromise_-Enterprise-Security-Privacy-and-Compliance.pdf — checked 2026-11-10 - Compliance and security: CRIO says it supports 21 CFR Part 11, HIPAA, EU Annex 11 and GDPR; its SOC 2 and ISO 27001 statements cover its Google Cloud data centers, not CRIO itself. — source: https://www.clinicalresearch.io/about-crio/security-compliance/ — checked 2026-11-10 - Published pricing and terms: CRIO publishes no prices or pricing model. — source: https://www.clinicalresearch.io/ — checked 2026-11-10 - [RealTime-CTMS](https://bestclinicaltrialsoftware.com/software/realtime/): Independent research sites and site networks that want CTMS, eSource, eReg and participant payments from one vendor. - Study, participant and visit tracking: RealTime-CTMS tracks subjects from referral to completion, calculates visit target dates with window enforcement, and supports recruitment database queries and pre-screening tracking. — source: https://realtime-eclinical.com/solutions/ctms/ — checked 2026-11-10 - Site finances: It tracks budgets, completed visits, invoices with aging reports, receivables, payables and subject stipends through SitePay, but RealTime does not describe research billing compliance features. — source: https://realtime-eclinical.com/solutions/ctms/ — checked 2026-11-10 - Connected site tools and integrations: RealTime offers its own eSource, eReg/eISF, SitePay, eConsent and the RealTime Connect API, but lists no EHR integration. — source: https://realtime-eclinical.com/ — checked 2026-11-10 - Proven fit and adoption: RealTime publishes client testimonials and results, such as Cedar Health Research, but no customer or site count. — source: https://realtime-eclinical.com/ — checked 2026-11-10 - Compliance and security: RealTime states its platform supports 21 CFR Part 11, GCP, SOC 2, HIPAA and GDPR-compliant workflows, but does not name its SOC 2 report type. — source: https://realtime-eclinical.com/solutions/ereg-eisf/ — checked 2026-11-10 - Published pricing and terms: RealTime's pricing page offers pricing on request only, with no prices or model. — source: https://realtime-eclinical.com/pricing/ — checked 2026-11-10 - [Veeva SiteVault CTMS](https://bestclinicaltrialsoftware.com/software/veeva-sitevault/): Small and mid-size sites with up to 20 active studies, especially sites already using SiteVault eISF with sponsors on Veeva. - Study, participant and visit tracking: SiteVault CTMS supports study-specific visit calendars and real-time logging of visits and procedures; Veeva does not describe recruitment features. — source: https://sites.veevavault.help/gr/sitevault/ctms/ctms-faq/ — checked 2026-11-10 - Site finances: It tracks study budgets, generates invoices automatically, reconciles payments and reports earned versus forecasted revenue, with no research billing compliance features described. — source: https://sites.veevavault.help/gr/sitevault/ctms/ctms-faq/ — checked 2026-11-10 - Connected site tools and integrations: It shares data with SiteVault eISF and eConsent and with sponsors on Veeva's platform; API access is an Enterprise feature, and no eSource or EHR integration is described. — source: https://sites.veevavault.help/gr/sitevault/ctms/ctms-faq/ — checked 2026-11-10 - Proven fit and adoption: Veeva announced SiteVault CTMS in April 2025 with initial release planned for August 2025, and publishes no CTMS-specific customer count. — source: https://www.veeva.com/resources/veeva-announces-research-site-clinical-trial-management-system/ — checked 2026-11-10 - Compliance and security: Veeva states SiteVault CTMS is built to comply with 21 CFR Part 11, HIPAA and GDPR, and Veeva's trust page lists ISO 27001 and a SOC 2 Type II report. — source: https://sites.veevavault.help/gr/sitevault/ctms/ctms-faq/ — checked 2026-11-10 - Published pricing and terms: SiteVault Free, which includes CTMS, eISF and eConsent, costs nothing for sites with 20 or fewer concurrent active studies. — source: https://sites.veevavault.help/gr/sitevault/ctms/ctms-faq/ — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Research sites and study teams that need ongoing participant engagement, screening, consent, questionnaires and follow-up across clinical trials and research studies - Study, participant and visit tracking: Dashboards show participant check-ins and questionnaire progress. This is participant follow-up, not a claim of full site visit-calendar or monitoring management. — source: https://www.weguide.health/platform/analytics — checked 2026-11-12 - Site finances: No public evidence reviewed establishes study-budget, sponsor-invoicing or site-receivables workflows in WeGuide. Its published role is a participant layer alongside the CTMS. — source: https://www.weguide.health/blog/what-is-clinical-trial-management-system-ctms — checked 2026-11-12 - Connected site tools and integrations: The Integration Engine connects participant data with REDCap and other EDC systems using REST or FHIR APIs. Confirm any specific CTMS connector and field mapping. — source: https://www.weguide.health/integration-engine — checked 2026-11-12 - Proven fit and adoption: BRACE and INHERIT document participant research deployments. These examples are not CTMS customer counts or evidence that WeGuide performs full site operations. — source: https://www.weguide.health/multilingual-health-research — checked 2026-11-12 - Compliance and security: WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Published pricing and terms: WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [Velos eResearch](https://bestclinicaltrialsoftware.com/software/wcg-velos/): Academic medical centers, hospitals and multi-center research networks that need deep Epic integration, including on-premise deployments. - Study, participant and visit tracking: At UMMC, every participant is enrolled in Velos, which searches Epic for patient records and links enrolled participants to the study in Epic; WCG does not describe recruitment or pre-screening workflows. — source: https://umc.edu/Research/Research-Offices/Clinical-Trials/Researchers/Road-Map/Study-Start-Up/Study-Set-Up/Velos%20FAQs.html — checked 2026-11-10 - Site finances: At UMMC, Velos handles invoicing and collections, and each study's billing calendar, pricing and research designation feed to Epic. — source: https://umc.edu/Research/Research-Offices/Clinical-Trials/Researchers/Road-Map/Study-Start-Up/Study-Set-Up/Velos%20FAQs.html — checked 2026-11-10 - Connected site tools and integrations: WCG lists its own EDC and eSource, eConsent, a participant portal and APIs, plus integrations with EHRs, IRB, billing and eRegulatory binders; eRegulatory is an integration, not a native module. — source: https://www.wcgclinical.com/wp-content/uploads/2022/03/ctms-and-crms-for-sites.pdf — checked 2026-11-10 - Proven fit and adoption: WCG reports one client running 77,000+ studies with 97,000+ users and another with 120 locations, but publishes no customer count. — source: https://www.wcgclinical.com/wp-content/uploads/2023/11/WCG-eResearch-CTMS.pdf — checked 2026-11-10 - Compliance and security: WCG holds a HIPAA certification that covers eResearch and says Velos meets 21 CFR Part 11, but its ISO 27001:2022 certificate covers WCG products without naming Velos. — source: https://www.wcgclinical.com/about/certifications — checked 2026-11-10 - Published pricing and terms: WCG publishes no Velos prices; it offers an Enterprise edition and an eXpress edition it calls affordable. — source: https://www.wcgclinical.com/wp-content/uploads/2022/03/ctms-and-crms-for-sites.pdf — checked 2026-11-10 - [Best eCOA platforms](https://bestclinicaltrialsoftware.com/best/ecoa-platforms/): Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial. - [Medidata eCOA](https://bestclinicaltrialsoftware.com/software/medidata/): Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform - Validated instrument library and licensing: 2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service. — source: https://www.medidata.com/en/patient-experience/ecoa-solution/ — checked 2026-11-10 - Regulatory compliance and track record: Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published. — source: https://www.medidata.com/en/about-us/news-and-press/medidatas-experience-based-ai-earns-top-luminary-rating-in-everest-group-2026-review/ — checked 2026-11-10 - Global scale and languages: 200+ languages and dialects, 1,600+ eCOA studies, 90K+ sites and 460+ sponsors. — source: https://www.medidata.com/en/patient-experience/ecoa-solution/ — checked 2026-11-10 - Capture modes and integrations: BYOD (iOS, Android), provisioned devices and web; data flows into Rave EDC; Sensor Cloud is listed among Patient Cloud applications. — source: https://www.medidata.com/en/patient-experience/ecoa-solution/ — checked 2026-11-10 - Time to launch and self-service build: Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard. — source: https://www.medidata.com/en/patient-experience/ecoa-solution/ — checked 2026-11-10 - Published pricing and terms: No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees. — source: https://www.medidata.com/en/cloud-service/ — checked 2026-11-10 - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): Biotech, device and academic teams that want eCOA, eConsent and EDC in one platform with a self-service option - Validated instrument library and licensing: Library of validated instruments (EORTC, FACT-G, EQ-5D, SF-36, PROMIS); Professional Services manages scale licensing and validation; library size not published. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Regulatory compliance and track record: Fully validated, 21 CFR Part 11 and GxP compliant platform used in 6,100+ trials; no regulatory approval counts published. — source: https://www.castoredc.com/ecoa-clinical-trials-software-system-solutions/ — checked 2026-11-10 - Global scale and languages: 80+ languages through translation services, 10+ pre-translated interface languages and 24/7 support. — source: https://www.castoredc.com/ecoa-clinical-trials-software-system-solutions/ — checked 2026-11-10 - Capture modes and integrations: BYOD app, browser, SMS and messaging apps, site tablet mode and provisioned devices; integrates with major EDCs via REST API and webhooks. Wearable or sensor capture not documented. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Time to launch and self-service build: Self-service and low-complexity eCOA builds go live in weeks; managed builds reach UAT in 4 to 8 weeks. — source: https://www.castoredc.com/ecoa-services/ — checked 2026-11-10 - Published pricing and terms: Pricing process published: itemized, fixed-scope proposal with change-control terms within 5 business days, plus a Castor Essentials package for early-stage companies; no prices. — source: https://www.castoredc.com/pricing/ — checked 2026-11-10 - [Clario](https://bestclinicaltrialsoftware.com/software/clario/): Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints - Validated instrument library and licensing: Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists. — source: https://clario.com/solutions/ecoa/ — checked 2026-11-10 - Regulatory compliance and track record: States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately. — source: https://clario.com/ — checked 2026-11-10 - Global scale and languages: Studies in over 120 countries and over 100 languages; 25 years of DCT and hybrid trials. — source: https://clario.com/solutions/ecoa/ — checked 2026-11-10 - Capture modes and integrations: BYOD, web or provisioned devices, plus pre-validated connected devices (CGM, glucose meters, Opal motion sensors) integrated with the eCOA device. — source: https://clario.com/solutions/ecoa/ — checked 2026-11-10 - Time to launch and self-service build: eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published. — source: https://clario.com/solutions/ecoa/ — checked 2026-11-10 - Published pricing and terms: Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only. — source: https://clario.com/solutions/ecoa/ — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Clinical trials and research studies where ongoing participant engagement is central, with electronic assessments, reminders and follow-up in one study app - Validated instrument library and licensing: WeGuide publishes an assessment-instrument library and describes instrument licensing and digital-migration support. Confirm permissions and validation responsibilities for each chosen instrument. — source: https://www.weguide.health/blog/ecoa-validation — checked 2026-11-12 - Regulatory compliance and track record: WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Global scale and languages: WeGuide describes BRACE across five countries and INHERIT in ten languages. These are examples of participant outcome collection, rather than a claim of enterprise-scale eCOA deployment. — source: https://www.weguide.health/multilingual-health-research — checked 2026-11-12 - Capture modes and integrations: Electronic participant outcome forms connect to existing EDC systems through the Integration Engine. Provisioned-device fleet delivery is not established by this source. — source: https://www.weguide.health/integration-engine — checked 2026-11-12 - Time to launch and self-service build: The no-code study builder supports team configuration; WeGuide states a typical two-to-four-week configuration period with implementation support. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Published pricing and terms: WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [Kayentis](https://bestclinicaltrialsoftware.com/software/kayentis/): Phase II-III sponsors that want a specialist eCOA vendor with site and patient helpdesk support - Validated instrument library and licensing: Questionnaire library and translation tools built with linguistic validation agencies; licensing and validation handled with language-service partners. — source: https://kayentis.com/clinform-ecoa-solution/ecoa-electronic-clinical-outcome-assessment/ — checked 2026-11-10 - Regulatory compliance and track record: States a strong foundation in supporting labeling claims and NDAs without counts; 2021 brochure documents Part 11, GDPR and GAMP5 validation. — source: https://kayentis.com/ — checked 2026-11-10 - Global scale and languages: 280+ clinical trials in 85 countries and 120 languages (2023 release). — source: https://kayentis.com/resources/kayentis-raises-further-5m-to-boost-us-activities/ — checked 2026-11-10 - Capture modes and integrations: BYOD, provisioned devices, web browser and interview mode; connects to IRT, patient portals, wearables and EDC/CDMS. — source: https://kayentis.com/clinform-ecoa-solution/ecoa-electronic-clinical-outcome-assessment/ — checked 2026-11-10 - Time to launch and self-service build: Set-up is vendor-led with protocol review and a questionnaire library; no timelines or self-service tooling published. — source: https://kayentis.com/clinform-ecoa-solution/ecoa-electronic-clinical-outcome-assessment/ — checked 2026-11-10 - Published pricing and terms: Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only. — source: https://kayentis.com/ — checked 2026-11-10 - [Medable](https://bestclinicaltrialsoftware.com/software/medable/): Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform - Validated instrument library and licensing: 400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked. — source: https://www.medable.com/platform/ecoa-epro — checked 2026-11-10 - Regulatory compliance and track record: States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Global scale and languages: 80+ countries and 120+ locales; device logistics from six global depots to 65+ countries. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Capture modes and integrations: eCOA, eConsent, TeleVisit and devices in one platform, BYOD or provisioned, with sensors and connectors to other clinical systems. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Time to launch and self-service build: Study Studio is a no-code visual builder; studies that took 16 to 20 weeks go live in 4 to 6 weeks, some in a day. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Published pricing and terms: Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - [Signant eCOA](https://bestclinicaltrialsoftware.com/software/signant/): CNS and other complex-endpoint trials that need clinician ratings, licensing support and global logistics - Validated instrument library and licensing: Library of 50+ instruments, many pre-approved by authors; scale licensing and management support; 50+ clinical and eCOA experts. — source: https://signanthealth.com/solutions/ecoa — checked 2026-11-10 - Regulatory compliance and track record: States it supported 25% of novel drug approvals across FDA and EMA in 2020-2025 (company-wide). — source: https://signanthealth.com/company/about-us — checked 2026-11-10 - Global scale and languages: Operates in 135+ countries, supports 600+ live eCOA studies and ran a BYOD study with 47,000+ participants. — source: https://signanthealth.com/resources/blog/ecoa-vendor-clinical-trials — checked 2026-11-10 - Capture modes and integrations: Provisioned, web and BYOD deployment, ePRO and complex ClinRO, and wearable sensors through the Ametris acquisition. — source: https://signanthealth.com/solutions-digital-health-technologies — checked 2026-11-10 - Time to launch and self-service build: Automation gives '33% faster eCOA launch timelines'; builds are delivered by Signant, no self-service eCOA designer published. — source: https://signanthealth.com/solutions/ecoa — checked 2026-11-10 - Published pricing and terms: Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only. — source: https://signanthealth.com/solutions/ecoa — checked 2026-11-10 - [YPrime](https://bestclinicaltrialsoftware.com/software/yprime/): Sponsors that want eCOA, IRT and eConsent from one vendor across many languages - Validated instrument library and licensing: Instrument licensing relationships and pre-validated eCOA libraries; library size and science team not published. — source: https://www.yprime.com/cro-ecoa-irt-partner/ — checked 2026-11-10 - Regulatory compliance and track record: Documents GxP and 21 CFR Part 11 compliance and an open client-audit program; nearly 1,000 studies, no approval counts; ISO 27001 in progress. — source: https://www.yprime.com/trust-with-certainty/ — checked 2026-11-10 - Global scale and languages: Localization in 250+ languages and deployment in 100+ countries. — source: https://www.yprime.com/ecoa/ — checked 2026-11-10 - Capture modes and integrations: BYOD, provisioned or both; wearables, glucometers and sensors; integrated eCOA, IRT and eConsent with EDC data workflows. — source: https://www.yprime.com/ecoa/ — checked 2026-11-10 - Time to launch and self-service build: Claims 47% faster eCOA study startup; builds are vendor-delivered, no self-service designer published. — source: https://www.yprime.com/cro-ecoa-irt-partner/ — checked 2026-11-10 - Published pricing and terms: Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only. — source: https://www.yprime.com/ecoa/ — checked 2026-11-10 - [Best eConsent software](https://bestclinicaltrialsoftware.com/best/econsent-software/): Sponsors, CROs, research sites and academic teams choosing eConsent software for clinical trials and research studies. - [Castor eConsent](https://bestclinicaltrialsoftware.com/software/castor/): Teams that want eConsent linked to Castor EDC and ePRO, with video consent visits - Consent experience and comprehension: Built-in video visits, knowledge-check questions, videos in forms, versioning and re-consent for amendments, remote, on-site or hybrid; LAR or assent flows not documented. — source: https://www.castoredc.com/econsent/ — checked 2026-11-10 - Compliance and regulatory track record: Part 11 compliant eSignatures, full audit trail and MFA; ISO 27001 certified; Castor platform used in 6,100+ trials. — source: https://www.castoredc.com/econsent/ — checked 2026-11-10 - Global scale and languages: Participant interface in 20 languages, forms in any language, EU or US data storage and a hybrid paper option. — source: https://helpdesk.castoredc.com/hc/en-us/articles/26949781057565-What-languages-does-Castor-eConsent-support — checked 2026-11-10 - Integrations and suite fit: Native integration with Castor EDC and ePRO, plus a RESTful API for other vendors. — source: https://www.castoredc.com/econsent/ — checked 2026-11-10 - Time to launch and self-service build: After account set-up, study teams create studies and build consent forms themselves; no turnaround times published. — source: https://helpdesk.castoredc.com/hc/en-us/articles/26181891641501-Castor-eConsent-and-CDMS-implementation-process — checked 2026-11-10 - Published pricing and terms: Published pricing process with itemized fixed-scope proposals and change-control terms; no prices. — source: https://www.castoredc.com/pricing/ — checked 2026-11-10 - [Florence eConsent](https://bestclinicaltrialsoftware.com/software/florence/): Sites and site networks already on Florence eBinders that want consent in the same system - Consent experience and comprehension: Remote and on-site consent on any device, remote identity verification, re-consent distribution and tracking; multimedia and comprehension checks not documented. — source: https://www.florencehc.com/products/econsent/ — checked 2026-11-10 - Compliance and regulatory track record: Compliant with technical requirements of Part 11, Annex 11 and ICH GCP; annual SOC 2 Type II; 88K sites in 90+ countries use Florence (platform-level). — source: https://www.florencehc.com/compliance/ — checked 2026-11-10 - Global scale and languages: Country-specific compliance reviews for eConsent in 90+ countries; a customer institution reports English and Spanish as the supported languages. — source: https://www.florencehc.com/compliance/ — checked 2026-11-10 - Integrations and suite fit: eConsent is accessed through Florence eBinders (eISF) and links to eTMF. — source: https://www.florencehc.com/products/econsent/ — checked 2026-11-10 - Time to launch and self-service build: No build process, self-service builder or turnaround published. — source: https://www.florencehc.com/products/econsent/ — checked 2026-11-10 - Published pricing and terms: AWS Marketplace lists a $30,000 annual starter pack plus $125 per active study-site per month; no low-cost or free tier. — source: https://aws.amazon.com/marketplace/pp/prodview-pjn3ae3b2edfo — checked 2026-11-10 - [Medable Total Consent](https://bestclinicaltrialsoftware.com/software/medable/): Global sponsors that need eConsent in many locales, including wet-ink countries - Consent experience and comprehension: Instructional videos and knowledge checks, onsite or remote consent with eSignature or wet ink, multiple signatories where appropriate, template and version management. — source: https://www.medable.com/newsroom/medable-unifies-and-simplifies-consent-management-for-global-decentralized-and-hybrid-trials — checked 2026-11-10 - Compliance and regulatory track record: Designed to comply with Part 11, Annex 11, HIPAA, GDPR and ICH GCP; platform deployed in nearly 400 trials; no eConsent-specific counts published. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Global scale and languages: eConsent in more than 120 locales with local regulatory requirements and wet-ink templates. — source: https://www.medable.com/newsroom/medable-unifies-and-simplifies-consent-management-for-global-decentralized-and-hybrid-trials — checked 2026-11-10 - Integrations and suite fit: Unified with Medable eCOA, TeleVisit and devices; connectors to other clinical systems. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - Time to launch and self-service build: Self-service authoring tools and a rapid onboarding option; no turnaround times published for consent. — source: https://www.medable.com/newsroom/medable-unifies-and-simplifies-consent-management-for-global-decentralized-and-hybrid-trials — checked 2026-11-10 - Published pricing and terms: Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - [Medidata Consent](https://bestclinicaltrialsoftware.com/software/medidata/): Sponsors running complex or pediatric trials on Rave who want consent tied to EDC - Consent experience and comprehension: Multimedia content, pre-visit access, pediatric assent by age cohort, multi-arm and re-consent workflows, remote and on-site consent with live video. — source: https://www.medidata.com/en/patient-experience/consent/ — checked 2026-11-10 - Compliance and regulatory track record: Regulatory-grade eSignatures and audit-ready workflows; 400+ studies, 175+ IRB/ECs, 11K+ sites and 420K+ patients. — source: https://www.medidata.com/en/patient-experience/consent/ — checked 2026-11-10 - Global scale and languages: 60+ countries, eIDAS-compliant signatures and a paper-to-digital upload for regions that require wet ink. — source: https://www.medidata.com/en/patient-experience/consent/ — checked 2026-11-10 - Integrations and suite fit: Unified with Rave EDC, eCOA and the wider Medidata platform. — source: https://www.medidata.com/en/patient-experience/consent/ — checked 2026-11-10 - Time to launch and self-service build: Claims 75% faster consent build with AI and configuration 'from months to weeks'; who configures is not stated as self-service. — source: https://www.medidata.com/en/patient-experience/consent/ — checked 2026-11-10 - Published pricing and terms: No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees. — source: https://www.medidata.com/en/cloud-service/ — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Clinical trials and research studies that need informed consent connected to ongoing participant engagement, questionnaires and follow-up - Consent experience and comprehension: The no-code consent builder supports video, audio and comprehension quizzes, electronic signatures, multiple signatories and representatives. Versions, reconsent and consent status are tracked in the study workflow. — source: https://www.weguide.health/platform/econsent — checked 2026-11-13 - Compliance and regulatory track record: WeGuide states ISO certification and support for HIPAA, GDPR and 21 CFR Part 11 requirements. Its public statements do not supply a current ISO certificate or SOC audit report. — source: https://www.weguide.health/platform/econsent — checked 2026-11-13 - Global scale and languages: WeGuide describes multilingual consent, including the INHERIT study, and participant research across five countries in BRACE. These are vendor-published study examples, not a country-by-country e-signature acceptance list. — source: https://www.weguide.health/platform/econsent — checked 2026-11-13 - Integrations and suite fit: Consent tasks link to screening and questionnaires in the same WeGuide program. The product page also documents connections to REDCap and other EDC or eClinical systems, with integration requirements scoped by the team. — source: https://www.weguide.health/platform/econsent — checked 2026-11-13 - Time to launch and self-service build: The no-code consent builder lets teams configure approved consent content. WeGuide states most eConsent studies can go live within days with team support. This is an eConsent setup claim; full app publishing and integration timelines require separate scoping. — source: https://www.weguide.health/platform/econsent — checked 2026-11-13 - Published pricing and terms: WeGuide publishes a per-study quote basis. Contact the team for the study-specific scope and price; no numerical price or free production tier is published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-13 - [REDCap e-Consent Framework](https://bestclinicaltrialsoftware.com/software/redcap/): Academic and non-profit teams that already use REDCap and can validate it themselves - Consent experience and comprehension: Consent built as REDCap surveys with an end-of-survey certification step, PDF archival and version footer; the framework is not a full eConsent process on its own. — source: https://norwichcrtu.uea.ac.uk/ctudocs_public/econsent_proj/Implementing_eConsent_in_REDCap_and_similar_EDC_systems_v1_0.pdf — checked 2026-11-10 - Compliance and regulatory track record: REDCap can be used in compliance with Part 11, HIPAA and GDPR, but validation depends on the hosting institution. — source: https://project-redcap.org/ — checked 2026-11-10 - Global scale and languages: 8,526 institutions in 167 countries; Multi-Language Management lets teams translate forms and the participant interface. — source: https://project-redcap.org/ — checked 2026-11-10 - Integrations and suite fit: Consent lives inside REDCap, a full EDC with an API. — source: https://project-redcap.org/ — checked 2026-11-10 - Time to launch and self-service build: Research teams build consent instruments themselves, often from institutional templates; turnaround depends on the host. — source: https://ctsi.utah.edu/cores-and-services/bmic/software-applications/econsent — checked 2026-11-10 - Published pricing and terms: Software and consortium support are free to non-profit organizations that join; not licensed to for-profit organizations. — source: https://projectredcap.org/join/ — checked 2026-11-10 - [Signant SmartSignals eConsent](https://bestclinicaltrialsoftware.com/software/signant/): Sponsors that want PDF or fully interactive eConsent inside a wider eCOA, EDC and RTSM suite - Consent experience and comprehension: Assent workflow, built-in comprehension Q&A, rich multimedia, content flagging, remote consent and re-consent with automated version control. — source: https://signanthealth.com/hubfs/Marketing%20Assets/Brochures/Brochure%20-%20Signant%20SmartSignals%20eConsent.pdf — checked 2026-11-10 - Compliance and regulatory track record: Regulatory-compliant, traceable audit trails and experience implementing eConsent for 'hundreds of protocols'; no exact counts. — source: https://signanthealth.com/company/news/signant-health-announces-the-release-of-expanded-and-enhanced-econsent-solutions — checked 2026-11-10 - Global scale and languages: Multi-language support with translation management; a published case study ran in 6 countries and 8 languages. — source: https://signanthealth.com/resources/smartsignals-econsent-brochure — checked 2026-11-10 - Integrations and suite fit: Embedded add-on to Signant's EDC with single logon, plus eClinical integration and SSO with site and sponsor systems. — source: https://signanthealth.com/solutions/unified-eclinical-platform — checked 2026-11-10 - Time to launch and self-service build: Self-service implementation with template libraries and Word import, or full service; no turnaround times published. — source: https://signanthealth.com/solutions/patient-engagement/econsent — checked 2026-11-10 - Published pricing and terms: No prices; a 2021 release names Silver, Gold and Platinum license tiers. — source: https://signanthealth.com/company/news/signant-health-announces-the-release-of-expanded-and-enhanced-econsent-solutions — checked 2026-11-10 - [Veeva SiteVault eConsent](https://bestclinicaltrialsoftware.com/software/veeva-sitevault/): Research sites that want free, validated eConsent unified with their eISF and CTMS - Consent experience and comprehension: In-person or remote consent in MyVeeva, images, videos and questions, extra signatories (guardian, witness, caregiver), automated versioning and amendment notification. — source: https://sites.veeva.com/sitevault-faq — checked 2026-11-10 - Compliance and regulatory track record: Fully validated by Veeva, Part 11 compliant eSignatures; SiteVault is used by 8,600+ sites (platform-level, no eConsent-specific counts). — source: https://sites.veeva.com/solutions/econsent — checked 2026-11-10 - Global scale and languages: About 88 participant locales in MyVeeva and an ink-signature upload path where eSignatures are not accepted; country counts for eConsent not published. — source: https://ecoa.veevavault.help/en/lr/912940/ — checked 2026-11-10 - Integrations and suite fit: Unified with SiteVault eISF and CTMS, connects to Veeva EDC and sponsor systems; open API in the Enterprise edition. — source: https://sites.veeva.com/plans — checked 2026-11-10 - Time to launch and self-service build: Sites turn IRB-approved PDFs into participant-ready eConsents in minutes and reuse templates across studies. — source: https://sites.veeva.com/hubfs/eConsent%20brief%202026.pdf — checked 2026-11-10 - Published pricing and terms: SiteVault Free includes eConsent for sites with up to 20 active studies; Enterprise by quote. — source: https://sites.veeva.com/plans — checked 2026-11-10 - [Best EDC systems for clinical trials](https://bestclinicaltrialsoftware.com/best/edc-systems/): Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols. - [Medidata Rave EDC](https://bestclinicaltrialsoftware.com/software/medidata/): Large sponsors and CROs running global Phase II and III programs that want EDC, RTSM, coding and eCOA from one vendor. - Track record in regulated multi-site trials: Medidata's Rave EDC page reports 38K+ studies, 1.8M+ users and 25+ years in use. — source: https://www.medidata.com/en/clinical-trial-products/clinical-data-management/edc-systems/ — checked 2026-11-10 - Study build and mid-study changes: Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs. — source: https://www.medidata.com/en/clinical-trial-products/clinical-data-management/edc-systems/ — checked 2026-11-10 - Compliance and security: Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers. — source: https://www.medidata.com/en/trust-and-transparency/ — checked 2026-11-10 - Platform breadth: Rave EDC connects to Medidata's own RTSM, Coder+, eCOA, eConsent, Imaging and Clinical Data Studio. — source: https://www.medidata.com/en/clinical-trial-products/clinical-data-management/edc-systems/ — checked 2026-11-10 - APIs and data standards: Rave Web Services is a REST API that exchanges data in CDISC ODM, and Medidata lists Health Record Connect for EHR data on its EDC page. — source: https://techblog.mdsol.com/2014/11/21/rwslib-a-rave-web-service-library.html — checked 2026-11-10 - Published pricing and terms: Medidata publishes no prices; its EDC page only says Rave Lite has a flexible pricing model. — source: https://www.medidata.com/en/clinical-trial-products/clinical-data-management/edc-systems/ — checked 2026-11-10 - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): Academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves. - Track record in regulated multi-site trials: Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs. — source: https://www.castoredc.com/about-castor/ — checked 2026-11-10 - Study build and mid-study changes: Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim. — source: https://www.castoredc.com/electronic-data-capture-system/ — checked 2026-11-10 - Compliance and security: Castor lists FDA 21 CFR Part 11, EU Annex 11 and ISO 27001 among its compliance standards. — source: https://www.castoredc.com/about-castor/ — checked 2026-11-10 - Platform breadth: Castor's EDC page lists eConsent, ePRO/eCOA and eSource; it lists no native trial supply management, coding or CTMS. — source: https://www.castoredc.com/electronic-data-capture-system/ — checked 2026-11-10 - APIs and data standards: Castor offers an open API, says it aligns with HL7 FHIR and integrates with EHRs, but makes no specific CDISC export claim. — source: https://www.castoredc.com/electronic-data-capture-system/ — checked 2026-11-10 - Published pricing and terms: No prices published; Castor's pricing page describes an itemized, fixed-scope proposal with change-control terms, sent within five business days. — source: https://www.castoredc.com/pricing/ — checked 2026-11-10 - [Medrio](https://bestclinicaltrialsoftware.com/software/medrio/): Small and mid-size sponsors and CROs that want a no-code EDC with RTSM, eCOA and eConsent from one vendor. - Track record in regulated multi-site trials: Medrio cites 20+ years of use, sites in 30+ countries and trials from early feasibility to pivotal studies, but its current pages show no study count. — source: https://www.medrio.com/products/edc/ — checked 2026-11-10 - Study build and mid-study changes: Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime. — source: https://www.medrio.com/products/edc/ — checked 2026-11-10 - Compliance and security: Medrio completed a SOC 2 Type 2 examination in 2022, and its EDC page states support for 21 CFR Part 11, ICH E6(R2), HIPAA and GDPR. — source: https://medrio.com/blog/medrio-completes-successful-type-2-system-and-organization-controls-soc-2-examination — checked 2026-11-10 - Platform breadth: Medrio lists EDC, ePRO/eCOA, eConsent, RTSM (randomization and supply), CTMS and eTMF; coding is not listed. — source: https://medrio.com/why-medrio/ — checked 2026-11-10 - APIs and data standards: Medrio mentions import and export APIs and industry-standard exports but publishes no API documentation or named CDISC format. — source: https://medrio.com/why-medrio/ — checked 2026-11-10 - Published pricing and terms: No prices published; Medrio describes its pricing as subscription-based. — source: https://medrio.com/blog/edc-study-build/ — checked 2026-11-10 - [OpenClinica](https://bestclinicaltrialsoftware.com/software/openclinica/): Academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange. - Track record in regulated multi-site trials: OpenClinica says its technology has powered over 15,000 studies and more than three million patients. — source: https://www.openclinica.com/ — checked 2026-11-10 - Study build and mid-study changes: OpenClinica offers drag-and-drop self-build with CDASH templates or a free expert-managed build, but does not publicly document how amendments deploy. — source: https://www.openclinica.com/solutions/electronic-data-capture-edc/ — checked 2026-11-10 - Compliance and security: OpenClinica states 21 CFR Part 11, ICH GCP, HIPAA and GDPR compliance and lists SOC 2 Type II and ISO 27001 certification. — source: https://www.openclinica.com/trust-and-compliance/ — checked 2026-11-10 - Platform breadth: OpenClinica lists EDC with eConsent, eCOA, randomization, EHR-to-EDC and reporting; it has no native trial supply management or coding. — source: https://www.openclinica.com/ — checked 2026-11-10 - APIs and data standards: OpenClinica documents a REST API that imports and retrieves clinical data as CDISC ODM 1.3.2 XML or JSON, and it offers EHR-to-EDC. — source: https://docs.openclinica.com/oc4/how-and-when-to-use-apis/oc4-clinicaldata-import-crf-data/ — checked 2026-11-10 - Published pricing and terms: OpenClinica publishes prices: EDC-only Launch at $750 a month with a 30-day free trial, and Core at $3,000 a month per study on a 12-month contract. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - [Oracle Clinical One](https://bestclinicaltrialsoftware.com/software/oracle/): Large sponsors and CROs that want data collection and randomization and supply management on one Oracle platform. - Track record in regulated multi-site trials: Everest Group rated Oracle a Leader in its 2024 EDC assessment, but we found no published Clinical One study or customer count. — source: https://www.viedoc.com/hubfs/02%20Documents/Reports/everest-group-edc-peak-matrix-assessment-2024.pdf — checked 2026-11-10 - Study build and mid-study changes: Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime. — source: https://docs.oracle.com/en/industries/life-sciences/clinical-one/study-design-information/manage-study-versions-during-study-conduct-period.html — checked 2026-11-10 - Compliance and security: Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One. — source: https://docs.oracle.com/en/industries/life-sciences/clinical-one/change-log/25_2_1-new-datasets-track-svfl-actions.html — checked 2026-11-10 - Platform breadth: Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations. — source: https://docs.oracle.com/en/industries/life-sciences/clinical-one/clinicalio/index.html — checked 2026-11-10 - APIs and data standards: Oracle documents about 18 REST APIs for Clinical One, ODM-format integrations, CDISC LAB data intake and a catalog of named integrations. — source: https://docs.oracle.com/en/industries/life-sciences/clinical-one/clinicalio/index.html — checked 2026-11-10 - Published pricing and terms: Oracle publishes no Clinical One prices or pricing model. — source: https://www.oracle.com/life-sciences/clinical-trials/data-collection/ — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems - Track record in regulated multi-site trials: Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions. — source: https://www.weguide.health/multilingual-health-research — checked 2026-11-13 - Study build and mid-study changes: Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material. — source: https://www.weguide.health/platform/form-builder — checked 2026-11-13 - Compliance and security: WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Platform breadth: Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed. — source: https://www.weguide.health/clinical-trial-solutions — checked 2026-11-13 - APIs and data standards: REST and FHIR integration methods are documented. A named CDISC-format export is not established in the reviewed public material. — source: https://www.weguide.health/integration-engine — checked 2026-11-12 - Published pricing and terms: WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [REDCap](https://bestclinicaltrialsoftware.com/software/redcap/): Academic and non-profit teams running investigator-initiated studies, as a free baseline. - Track record in regulated multi-site trials: The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research. — source: https://projectredcap.org/about/ — checked 2026-11-10 - Study build and mid-study changes: Teams build REDCap projects themselves in the online designer, and changes to live projects are drafted and approved in production mode. — source: https://www.fredhutch.org/content/dam/www/research/divisions/public-health-sciences/collaborative-data-services/files/rc101-redcap-at-fred-hutch.pdf — checked 2026-11-10 - Compliance and security: Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant. — source: https://projectredcap.org/software/ — checked 2026-11-10 - Platform breadth: REDCap includes randomization, e-Consent and participant surveys, but no trial supply management, coding or CTMS. — source: https://www.fredhutch.org/content/dam/www/research/divisions/public-health-sciences/collaborative-data-services/files/rc101-redcap-at-fred-hutch.pdf — checked 2026-11-10 - APIs and data standards: REDCap has an API and exports CDISC ODM (per Yale's REDCap guide), and the REDCap software page documents EHR data pulls over FHIR. — source: https://portal.redcap.yale.edu/sites/default/files/2025-09/REDCap_All_Purpose_Data_Tool_090925.pdf — checked 2026-11-10 - Published pricing and terms: REDCap is free for non-profit members of the REDCap Consortium; for-profit organizations are not eligible. — source: https://projectredcap.org/partners/join/ — checked 2026-11-10 - [Veeva EDC](https://bestclinicaltrialsoftware.com/software/veeva/): Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor. - Track record in regulated multi-site trials: Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count. — source: https://www.veeva.com/products/vault-edc/ — checked 2026-11-10 - Study build and mid-study changes: Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys. — source: https://www.veeva.com/eu/resources/implementing-study-amendments-without-downtime-or-data-migrations/ — checked 2026-11-10 - Compliance and security: Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11. — source: https://www.veeva.com/trust/ — checked 2026-11-10 - Platform breadth: Veeva's clinical data suite lists EDC, eCOA, RTSM (randomization and supply) and DQS data management, and Veeva also sells CTMS and eConsent. — source: https://www.veeva.com/products/clinical-data-management/ — checked 2026-11-10 - APIs and data standards: Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature. — source: https://developer-cdms.veevavault.com/api/26.1 — checked 2026-11-10 - Published pricing and terms: Veeva publishes no EDC prices or pricing model. — source: https://www.veeva.com/products/vault-edc/ — checked 2026-11-10 - [Viedoc](https://bestclinicaltrialsoftware.com/software/viedoc/): Sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users. - Track record in regulated multi-site trials: Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024. — source: https://www.viedoc.com/ — checked 2026-11-10 - Study build and mid-study changes: Viedoc offers a drag-and-drop designer with reusable templates and states that database updates go live without downtime or vendor handoffs. — source: https://www.viedoc.com/products/edc-software — checked 2026-11-10 - Compliance and security: Viedoc is certified to ISO 27001:2022, has a SOC 2 Type 2 report and runs a 21 CFR Part 11 test suite for every release. — source: https://www.viedoc.com/security-and-compliance — checked 2026-11-10 - Platform breadth: Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS. — source: https://www.viedoc.com/ — checked 2026-11-10 - APIs and data standards: Viedoc documents a web API (Swagger, OAuth 2.0) for data import and export and refers to CDISC-compliant formats, but names no ODM or SDTM export. — source: https://www.viedoc.com/viedoc-api — checked 2026-11-10 - Published pricing and terms: Viedoc publishes its pricing model (single-study or multi-study licenses, unlimited users, no setup fee for self-built studies) but no prices. — source: https://www.viedoc.com/pricing — checked 2026-11-10 - [Best ePRO software for clinical trials](https://bestclinicaltrialsoftware.com/best/epro-software/): Clinical-trial and research teams comparing participant-facing ePRO for clinical trials, investigator-led studies, cohorts and registries, with integrated EDC options for clinic-heavy protocols. - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Clinical trials and research studies where ongoing participant engagement, scheduled questionnaires and follow-up need to work together in a branded app - Participant app and study branding: Native iOS and Android participant apps with the organization’s branding, configured welcome screens and study features, and dedicated Apple and Google store listings under the organization’s name. — source: https://www.weguide.health/platform/white-labeling — checked 2026-11-12 - Questionnaires and scheduling: A curated assessment-instrument catalogue plus recurring engagements and enrollment-, response- or score-triggered follow-up. Instrument permissions and appropriate language versions must be checked for the study. — source: https://www.weguide.health/platform/program-builder — checked 2026-11-12 - Time to launch and self-service build: Research teams configure schedules, reminders, content, consent and forms in a no-code Program Builder. WeGuide states typical study configuration takes two to four weeks, with its delivery team alongside and app publishing and integrations scoped during implementation. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Compliance and security: WeGuide states ISO 27001:2022 certification, HIPAA support (BAA on request), GDPR and FDA 21 CFR Part 11 support, and TGA Class I registration (ARTG 355337). The public page does not supply the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - eConsent and data connections: eConsent in the same app plus an Integration Engine with REDCap, Castor and Medidata Rave connections over REST or FHIR APIs. — source: https://www.weguide.health/integration-engine — checked 2026-11-10 - Published pricing and terms: Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): Studies collecting substantial site-entered clinical data alongside ePRO, including sponsor-led trials and academic studies needing integrated EDC - Participant app and study branding: Castor Connect is a native iOS and Android app with offline completion, plus a browser option; it is Castor-branded, with no own-brand option documented. — source: https://helpdesk.castoredc.com/hc/en-us/articles/27187047287325-Castor-Connect-ePRO-app — checked 2026-11-10 - Questionnaires and scheduling: Validated instrument library with licensing and version control of scales handled by Castor, plus time- and action-based survey triggers. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Time to launch and self-service build: No-code builder, but Castor states eCOA builds reach UAT in 4 to 8 weeks for low-to-medium complexity with its managed services. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Compliance and security: Castor publishes its ISO/IEC 27001:2022 certificate, and its eCOA page states Part 11, Annex 11, HIPAA and GDPR support. — source: https://www.castoredc.com/wp-content/uploads/2025/08/ISO-27001-2022_Expiration-DEC-2026.pdf — checked 2026-11-10 - eConsent and data connections: EDC, eCOA and eConsent are native modules of one platform, with REST APIs and webhooks. — source: https://www.castoredc.com/about-castor/ — checked 2026-11-10 - Published pricing and terms: No prices published; Castor describes flat-rate per-study licensing with no per-subject fees and quotes on request. — source: https://www.castoredc.com/why-castor/castor-vs-openclinica/ — checked 2026-11-10 - [Datacubed Health](https://bestclinicaltrialsoftware.com/software/datacubed/): Sponsor studies that want an engagement-focused eCOA app with expert configuration - Participant app and study branding: BYOD on iOS and Android, online or offline, with reminders; an own-brand option is not documented. — source: https://www.datacubed.com/product-suite/ — checked 2026-11-10 - Questionnaires and scheduling: No-code authoring with complex and cycle-based schedule logic for PRO, ClinRO, ObsRO and PerfO; no public instrument library. — source: https://www.datacubed.com/product-suite/ecoa-epro/ — checked 2026-11-10 - Time to launch and self-service build: Datacubed states a 7 to 10 week average from setup to go-live, configured with its consultants. — source: https://www.datacubed.com/delivery-success/expert-consulting/ — checked 2026-11-10 - Compliance and security: States Part 11, HIPAA and GDPR compliance; no ISO 27001 or SOC 2 certification found on its public pages. — source: https://www.datacubed.com/delivery-success/fit-for-purpose-architecture/ — checked 2026-11-10 - eConsent and data connections: eConsent in the same ecosystem as ePRO, with API integrations to EDC, RTSM and EHR systems. — source: https://www.datacubed.com/product-suite/econsent/ — checked 2026-11-10 - Published pricing and terms: No pricing model, prices or contract terms published. — source: https://www.datacubed.com/ — checked 2026-11-10 - [Medrio](https://bestclinicaltrialsoftware.com/software/medrio/): Mid-size sponsors that want ePRO, eConsent and EDC configured in-house - Participant app and study branding: Web-based ePRO on any internet-connected device with customizable reminders; no native app. — source: https://medrio.com/solutions/epro/ — checked 2026-11-10 - Questionnaires and scheduling: No-code builder with branching, support for licensed or ad hoc assessments, and activation based on consent status or date; no ready instrument library is listed. — source: https://medrio.com/solutions/epro/ — checked 2026-11-10 - Time to launch and self-service build: No-code build by the study team, with Medrio stating contract to data capture in four weeks. — source: https://medrio.com/solutions/epro/ — checked 2026-11-10 - Compliance and security: Lists Part 11, Annex 11, GDPR, HIPAA, ISO 27001 and SOC 2. — source: https://medrio.com/data-safety-and-security/ — checked 2026-11-10 - eConsent and data connections: ePRO, eConsent and EDC on one platform. — source: https://medrio.com/solutions/econsent/ — checked 2026-11-10 - Published pricing and terms: No prices published; Medrio describes its pricing as subscription-based. — source: https://medrio.com/blog/edc-study-build/ — checked 2026-11-10 - [MyDataHelps (CareEvolution)](https://bestclinicaltrialsoftware.com/software/mydatahelps/): Academic and federally funded studies combining ePRO with wearable or EHR data, using self-service configuration or a scoped custom participant experience - Participant app and study branding: Participants normally use the shared MyDataHelps app. CareEvolution also documents a separate white-label All of Us app supporting enrollment, eConsent, ePRO and participant engagement; a custom deployment must be scoped. — source: https://careevolution.com/case-studies/facilitating-precision-medicine-research-through-the-all-of-us-research-program/ — checked 2026-11-12 - Questionnaires and scheduling: Library of validated instruments and NIH common data elements, schedules relative to participant events or criteria, and versioned screening and consent. — source: https://careevolution.com/mydatahelps/ — checked 2026-11-10 - Time to launch and self-service build: Self-service no-code Designer with a free account; CareEvolution states a trial can launch in hours. — source: https://careevolution.com/mydatahelps/ — checked 2026-11-10 - Compliance and security: States HIPAA and Part 11 compliance and NIST 800-53 controls assessed by a FedRAMP 3PAO with an NIH Authority to Operate, but names no ISO 27001 or SOC 2 certification. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - eConsent and data connections: eConsent with e-signatures, a documented two-way REDCap integration, and REST APIs and SDKs. — source: https://support.mydatahelps.org/redcap-integration-overview — checked 2026-11-10 - Published pricing and terms: A free Designer account to build and explore a study; paid pricing for running studies is not published. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - [OpenClinica](https://bestclinicaltrialsoftware.com/software/openclinica/): Small and mid-size teams that want published prices and ePRO on the same EDC - Participant app and study branding: Browser-based participant dashboard reached by secure link, with SMS and email reminders and an offline mode for forms; no native app. — source: https://www.openclinica.com/solutions/participate-electronic-patient-reported-outcomes-epro/ — checked 2026-11-10 - Questionnaires and scheduling: Form builder with visual analog scales, images and logic, and per-participant form availability; no validated instrument library is documented. — source: https://docs.openclinica.com/oc4/participate/ — checked 2026-11-10 - Time to launch and self-service build: Drag-and-drop designer or a free expert-managed build, with launch stated at 2 to 3 weeks. — source: https://www.openclinica.com/edc-with-free-study-build/ — checked 2026-11-10 - Compliance and security: Lists 21 CFR Part 11, HIPAA and GDPR compliance with SOC 2 Type II and ISO 27001 certification. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - eConsent and data connections: EDC, ePRO and eConsent in one platform, with an import and export API. — source: https://www.openclinica.com/solutions/econsent/ — checked 2026-11-10 - Published pricing and terms: Publishes prices ($750 per month for the Launch plan, $3,000 per month per study for Pro) and a 30-day free trial. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - [REDCap](https://bestclinicaltrialsoftware.com/software/redcap/): Nonprofit research teams whose institution already runs REDCap - Participant app and study branding: MyCap is a free native iOS and Android app with offline entry, push reminders and messaging; it is MyCap-branded, not the study's own. — source: https://projectmycap.org/frequently-asked-questions-faqs/ — checked 2026-11-10 - Questionnaires and scheduling: The REDCap Shared Library holds curated instruments reviewed by a library committee, and MyCap schedules tasks; validated instruments still need permission from their owners. — source: https://projectredcap.org/resources/library/ — checked 2026-11-10 - Time to launch and self-service build: Self-service online designer, but no public go-live timeline, and a new institution must first license and install REDCap. — source: https://projectredcap.org/about/faq/ — checked 2026-11-10 - Compliance and security: REDCap can be installed in compliance with HIPAA, Part 11 and GDPR, but compliance depends on each hosting institution and there is no vendor certification. — source: https://project-redcap.org/software/ — checked 2026-11-10 - eConsent and data connections: REDCap is itself an EDC with an e-Consent Framework and an API, and MyCap syncs into it. — source: https://kb.wisc.edu/smph/informatics/142489 — checked 2026-11-10 - Published pricing and terms: The REDCap license is free for nonprofit consortium members and MyCap is free; for-profit teams must use paid hosting. — source: https://projectredcap.org/about/faq/ — checked 2026-11-10 - [Viedoc](https://bestclinicaltrialsoftware.com/software/viedoc/): Sponsors and CROs that want ePRO inside an established EDC with per-study licensing - Participant app and study branding: Viedoc Me is a web app on participants' own devices with email and SMS reminders; no download and no offline entry. — source: https://www.viedoc.com/epro-software-clinical-trials — checked 2026-11-10 - Questionnaires and scheduling: Configurable windows and schedules, including events triggered by EDC data; no validated instrument library is listed. — source: https://www.viedoc.com/epro-software-clinical-trials — checked 2026-11-10 - Time to launch and self-service build: Self-service designer, but Viedoc states most studies go live in 8 to 12 weeks (self-service builds can launch in a day). — source: https://www.viedoc.com/products/edc-software — checked 2026-11-10 - Compliance and security: ISO 27001:2022-certified ISMS and a SOC 2 Type 2 report, with stated Part 11, HIPAA and GDPR compliance. — source: https://www.viedoc.com/security-and-compliance — checked 2026-11-10 - eConsent and data connections: ePRO, EDC and Part 11 eSignature consent in one suite, with a REST API. — source: https://www.viedoc.com/products/esignature — checked 2026-11-10 - Published pricing and terms: Publishes a per-study, per-module licensing model with unlimited users and nonprofit and academic pricing, but no prices. — source: https://www.viedoc.com/pricing — checked 2026-11-10 - [Best eTMF software](https://bestclinicaltrialsoftware.com/best/etmf-software/): Sponsors and CROs that own and maintain the trial master file (TMF) and need an electronic TMF system. - [Veeva eTMF](https://bestclinicaltrialsoftware.com/software/veeva/): Mid-size to large sponsors and CROs that want the eTMF on the same platform as CTMS and study start-up, with direct site exchange - TMF Reference Model and inspection readiness: Veeva aligns the TMF index with the TMF Reference Model, tracks completeness through expected document lists and milestones, and gives auditors and inspectors their own access. — source: https://www.veeva.com/blog/top-28-vault-etmf-features-to-drive-inspection-readiness/ — checked 2026-11-10 - Document capture and AI automation: TMF Bot auto-classifies documents with a configurable confidence threshold and extracts study, country and site metadata at upload in 30+ languages. — source: https://pantheon.veeva.com/wp-content/uploads/2025/08/Veeva_eTMF_TMF-Bot_Features-Brief.pdf — checked 2026-11-10 - CRO and site collaboration: Site Connect exchanges documents with sites and files what is sent and received into eTMF automatically, with two-way exchange for sites on SiteVault. — source: https://www.veeva.com/products/veeva-site-connect/ — checked 2026-11-10 - Integrations and platform: eTMF shares one data model with Veeva's Clinical Operations applications in a single Vault, and the Vault REST API is publicly documented (general.veevavault.dev). — source: https://clinical.veevavault.help/en/lr/4660/ — checked 2026-11-10 - Compliance and validation evidence: Veeva lists ISO 27001 audits and a SOC 2 Type II report, and provides a validation package (IQ/OQ, trace matrices, summary report) for each Vault release. — source: https://www.veeva.com/trust/ — checked 2026-11-10 - Adoption and track record: Veeva reported in June 2023 that more than 450 companies, including 18 of the top 20 pharmas and 4 of the top 6 CROs, use Vault eTMF. — source: https://www.veeva.com/resources/more-than-450-companies-adopt-veeva-vault-etmf-for-improved-trial-efficiency-and-inspection-readiness/ — checked 2026-11-10 - [Egnyte eTMF](https://bestclinicaltrialsoftware.com/software/egnyte/): Emerging biotechs that already use Egnyte for content and want a GxP eTMF in the same system - TMF Reference Model and inspection readiness: The eTMF page lists a CDISC TMF Reference Model, completeness metrics, QC dashboards, milestone management and read-only inspector access. — source: https://www.egnyte.com/products/life-sciences/etmf — checked 2026-11-10 - Document capture and AI automation: Egnyte says AI automatically tags and routes incoming documents, with document-type classification in its top plan; metadata extraction is not described. — source: https://www.egnyte.com/solutions/life-sciences — checked 2026-11-10 - CRO and site collaboration: Role-based permissions and watermarked external sharing let CROs and sites see only their own content; no site portal or eISF exchange is described. — source: https://www.egnyte.com/solutions/life-sciences — checked 2026-11-10 - Integrations and platform: Documented integrations are general (Microsoft 365, Google Workspace, lab instruments); no CTMS integration or eTMF API is described. — source: https://www.egnyte.com/solutions/life-sciences — checked 2026-11-10 - Compliance and validation evidence: Egnyte states ISO/IEC 27001:2022 certification and SOC 2 Type 2, and says its life sciences platform meets 21 CFR Part 11 and Annex 11 requirements with a validation package. — source: https://www.egnyte.com/compliance-standards — checked 2026-11-10 - Adoption and track record: Egnyte reports 600+ life sciences customers on its platform; no eTMF-specific count is published. — source: https://www.egnyte.com/products/life-sciences/etmf — checked 2026-11-10 - [Ennov eTMF](https://bestclinicaltrialsoftware.com/software/ennov/): Sponsors and CROs that want an eTMF with built-in basic CTMS, in the cloud or on premises - TMF Reference Model and inspection readiness: Ennov eTMF is preconfigured to the TMF Reference Model, with required document lists and dashboards for completeness, QC and timeliness; inspector access is not described. — source: https://en.ennov.com/solutions/clinical/ennov-etmf/ — checked 2026-11-10 - Document capture and AI automation: Smart Templates plan TMF placeholders from study data, with scanner integration and automated PDF rendering; eTMF AI classification appears only in a 2025 AI feature deck. — source: https://en.ennov.com/solutions/clinical/ennov-etmf/ — checked 2026-11-10 - CRO and site collaboration: Ennov lists flexible user and partner access controls across sponsors, CROs and sites; no site portal or eISF exchange is described. — source: https://en.ennov.com/solutions/clinical/ennov-etmf/ — checked 2026-11-10 - Integrations and platform: The eTMF includes basic CTMS functions and upgrades to full Ennov CTMS or integrates with another CTMS; we found no public API documentation. — source: https://en.ennov.com/solutions/clinical/ennov-etmf/ — checked 2026-11-10 - Compliance and validation evidence: The eTMF page lists 21 CFR Part 11 compliance, and Ennov states ISO/IEC 27001 and ISO 9001:2015 certification for its software development and operations. — source: https://en.ennov.com/about/ — checked 2026-11-10 - Adoption and track record: Ennov reports more than 650 companies and 500,000 users across all its products; no eTMF-specific count is published. — source: https://en.ennov.com/about/ — checked 2026-11-10 - [Florence eTMF](https://bestclinicaltrialsoftware.com/software/florence/): Sponsors and CROs whose sites already use Florence eBinders and who want site documents to flow into the TMF - TMF Reference Model and inspection readiness: Florence shows missing and expired documents and milestone dashboards, but its public eTMF pages do not describe a TMF Reference Model structure or inspector access. — source: https://florencehc.com/products/etmf/ — checked 2026-11-10 - Document capture and AI automation: Florence syncs documents into the eTMF by email and in October 2026 announced AI classification that recommends document type and filing location for user approval; metadata extraction is not described. — source: https://www.tmcnet.com/usubmit/2026/10/27/10470268.htm — checked 2026-11-10 - CRO and site collaboration: Sponsors connect with each site's Florence eISF through SiteLink to collect, route and query site documents inside the eTMF. — source: https://florencehc.com/products/etmf/ — checked 2026-11-10 - Integrations and platform: Florence says its eTMF has an open API and can stand alone or connect to an existing eTMF; it has no CTMS of its own. — source: https://www.florencehc.com/florence-etmf-faq/ — checked 2026-11-10 - Compliance and validation evidence: Florence has an annual third-party SOC 2 Type II attestation (report under NDA), and its eTMF FAQ states Part 11-compliant electronic records and signatures. — source: https://florencehc.com/security-controls/ — checked 2026-11-10 - Adoption and track record: Florence reports 88,000+ research sites and 600+ life science organizations on its platform; no eTMF-only count is published. — source: https://www.florencehc.com/ — checked 2026-11-10 - [Medidata eTMF](https://bestclinicaltrialsoftware.com/software/medidata/): Sponsors already on Rave EDC and Medidata CTMS who want the TMF on the same platform - TMF Reference Model and inspection readiness: Medidata states full support for the DIA TMF Reference Model and dashboards for quality, timeliness and completeness; inspector access is not described. — source: https://www.medidata.com/en/study-experience/etmf/ — checked 2026-11-10 - Document capture and AI automation: The page describes auto-filing, intelligent placeholders and auto-naming, but no AI classification. — source: https://www.medidata.com/en/study-experience/etmf/ — checked 2026-11-10 - CRO and site collaboration: Medidata describes role-based collaboration across sponsors, CROs and sites with a site-focused experience, but no eISF connection. — source: https://www.medidata.com/en/study-experience/etmf/ — checked 2026-11-10 - Integrations and platform: eTMF is unified with Rave and Medidata CTMS, and CTMS monitoring visit reports file into the TMF automatically; no eTMF API is described. — source: https://www.medidata.com/en/study-experience/etmf/ — checked 2026-11-10 - Compliance and validation evidence: Medidata lists an ISO 27001:2022 certificate and a SOC 2+ Type II audit, and says its position statements cover 21 CFR Part 11 and EU Annex 11. — source: https://www.medidata.com/en/trust-and-transparency/ — checked 2026-11-10 - Adoption and track record: Medidata reports 2,300 organizations across its whole platform; no eTMF-specific count is published. — source: https://www.medidata.com/en/company/ — checked 2026-11-10 - [Montrium eTMF Connect](https://bestclinicaltrialsoftware.com/software/montrium/): Small and mid-size biotechs that want a straightforward eTMF with published plan tiers - TMF Reference Model and inspection readiness: Montrium states alignment with TMF Reference Model 3.3.1, completeness reporting at study, country and site level, and dedicated inspector access. — source: https://montrium.com/etmf-connect — checked 2026-11-10 - Document capture and AI automation: eTMF Connect offers batch upload and indexing, study email inboxes and auto-filing by naming convention; AI-assisted indexing appears only in a webinar banner. — source: https://montrium.com/etmf-connect — checked 2026-11-10 - CRO and site collaboration: Sites can email documents to study inboxes without an account and upload to placeholders, with role-based access and Word co-authoring, but there is no eISF connection. — source: https://montrium.com/etmf-connect — checked 2026-11-10 - Integrations and platform: The only documented integration is document collaboration in Microsoft Word; no CTMS integration or API is described. — source: https://montrium.com/pricing — checked 2026-11-10 - Compliance and validation evidence: Montrium states 21 CFR Part 11 and Annex 11 alignment and a completed SOC 2 Type I audit (not Type 2). — source: https://www.montrium.com/trust-center — checked 2026-11-10 - Adoption and track record: Montrium says the product is trusted by thousands of TMF professionals and shows about 15 client logos; no customer count is published. — source: https://montrium.com/etmf-connect — checked 2026-11-10 - [PhlexTMF](https://bestclinicaltrialsoftware.com/software/phlexglobal/): Sponsors overseeing CRO-run TMFs who want TMF quality review and expert services alongside the software - TMF Reference Model and inspection readiness: PhlexTMF tracks expected versus received documents by trial, country and site, exports in the Exchange Mechanism format, and PhlexTMF for Viewing gives inspectors access to closed-study TMFs. — source: https://www.phlexglobal.com/etmf-software — checked 2026-11-10 - Document capture and AI automation: Cencora describes AI-assisted indexing with pre-trained neural networks that identify and extract attribute values from TMF documents at upload. — source: https://www.cencora.com/-/media/assets/corporate/global/pdfs/cencora-tmf-fact-flyer---phlextmf-software.pdf — checked 2026-11-10 - CRO and site collaboration: A PhlexTMF for CROs edition and built-in eQuery tracking support sponsor and CRO oversight; no site exchange is documented. — source: https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services — checked 2026-11-10 - Integrations and platform: Exchange Mechanism export to other eTMF systems is documented, but we found no current named integrations or public API. — source: https://www.phlexglobal.com/etmf-software — checked 2026-11-10 - Compliance and validation evidence: Needs facts — checked 2026-11-10 - Adoption and track record: Phlexglobal says hundreds of sponsor and CRO companies rely on its eTMF and services; no product-only count is published. — source: https://phlexglobal.com/about-phlexglobal — checked 2026-11-10 - [Trial Interactive eTMF](https://bestclinicaltrialsoftware.com/software/trial-interactive/): Sponsors and CROs that want eTMF software and TMF processing services from one vendor - TMF Reference Model and inspection readiness: Trial Interactive offers pre-configured TMF reference models, milestone-based completeness tracking and KPI dashboards, but its public pages do not describe inspector access or Exchange Mechanism support. — source: https://www.trialinteractive.com/etmf-tmf-solutions/etmf — checked 2026-11-10 - Document capture and AI automation: The eTMF page states AI classification across 424+ TMF categories with metadata extraction, plus automatic email capture and bulk upload. — source: https://www.trialinteractive.com/etmf-tmf-solutions/etmf — checked 2026-11-10 - CRO and site collaboration: Site Collaboration lets sites share completed documents directly with the connected eTMF, and eISF files flow into the eTMF. — source: https://www.trialinteractive.com/site-collaboration — checked 2026-11-10 - Integrations and platform: CTMS and study start-up run on the same platform and the eTMF has pre-built connectors to other eClinical systems, but we found no public API documentation. — source: https://www.trialinteractive.com/etmf-tmf-solutions/etmf — checked 2026-11-10 - Compliance and validation evidence: Trial Interactive lists 21 CFR Part 11, EU Annex 11, SSAE 16 SOC 2 Type 2, ISO 9001 and HITRUST CSF. — source: https://www.trialinteractive.com/ — checked 2026-11-10 - Adoption and track record: Trial Interactive reports 250+ sponsor clients, 60+ CRO clients and about 15,000 studies managed a year. — source: https://www.trialinteractive.com/ — checked 2026-11-10 - [Best patient registry software](https://bestclinicaltrialsoftware.com/best/patient-registry-software/): Research teams running patient registries and long-term cohort studies that collect data reported by participants themselves. - [ArborMetrix](https://bestclinicaltrialsoftware.com/software/arbormetrix/): Medical societies and health systems running clinical quality registries that add patient-reported outcomes - Participant app and retention: PRO surveys on any web-connected device, sent by email, text or phone follow-up on an automated cadence, with education content inside the survey; no native app. — source: https://www.arbormetrix.com/amxengage/ — checked 2026-11-10 - Long-term follow-up and PRO instruments: Surveys built to standard instruments such as ODI and PROMIS, or custom ones, distributed on a configurable automated cadence; no ready instrument library is described. — source: https://www.arbormetrix.com/amxengage/ — checked 2026-11-10 - Remote enrolment and eConsent: Patient consent is built into the survey experience, but patients are reached through pre-authenticated links rather than self-registration. — source: https://www.arbormetrix.com/amxengage/ — checked 2026-11-10 - Data linkage and export: Interoperability with EHRs, claims data and other sources; no API is documented. — source: https://www.arbormetrix.com/blog/5-reasons-arbormetrix-registry-vendor-of-choice/ — checked 2026-11-10 - Compliance and security: States HIPAA compliance; no 21 CFR Part 11, GDPR, ISO 27001 or SOC 2 statement found. — source: https://www.arbormetrix.com/blog/5-reasons-arbormetrix-registry-vendor-of-choice/ — checked 2026-11-10 - Published pricing and terms: No pricing information; pricing is available on request by email. — source: https://www.arbormetrix.com/amx360/ — checked 2026-11-10 - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): Academic and sponsor registries that want eConsent, ePRO and EDC from one vendor with per-study pricing - Participant app and retention: Castor Connect is a native iOS and Android app with offline completion, plus a browser option; messaging or education content for participants is not documented. — source: https://helpdesk.castoredc.com/hc/en-us/articles/27187047287325-Castor-Connect-ePRO-app — checked 2026-11-10 - Long-term follow-up and PRO instruments: A validated instrument library with licensing and version control handled by Castor, plus time- and action-based survey triggers. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Remote enrolment and eConsent: Participants can enroll themselves through a customizable patient portal landing page with pre-screening, and eConsent has form versioning and re-consent for amended protocols. — source: https://www.castoredc.com/econsent/ — checked 2026-11-10 - Data linkage and export: Open REST APIs and webhooks, with CSV, Excel and CDISC ODM import. — source: https://www.castoredc.com/blog/medical-device-study-no-code-edc/ — checked 2026-11-10 - Compliance and security: Castor publishes its ISO/IEC 27001:2022 certificate and states 21 CFR Part 11, HIPAA and GDPR support. — source: https://www.castoredc.com/wp-content/uploads/2025/08/ISO-27001-2022_Expiration-DEC-2026.pdf — checked 2026-11-10 - Published pricing and terms: No prices published; Castor describes flat-rate per-study licensing with no per-subject fees and no multi-year commitments. — source: https://www.castoredc.com/why-castor/castor-vs-openclinica/ — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Patient registries and cohort studies that need ongoing participant engagement, repeated reports and follow-up, with family and multilingual participation where required - Participant app and retention: White-label participant apps with push reminders, in-app messaging, education content timed to protocol milestones and televisits; the apps are native iOS and Android apps published under the organization's own name. — source: https://www.weguide.health/alternatives/fitabase — checked 2026-11-10 - Long-term follow-up and PRO instruments: A published assessment-instrument catalogue and Program Builder workflows for recurring questionnaires, reminders and enrollment- or response-triggered follow-up. Confirm the selected instrument’s permissions and digital-use requirements. — source: https://www.weguide.health/platform/program-builder — checked 2026-11-12 - Remote enrolment and eConsent: eScreening plus eConsent with version control, re-consent workflows and an audit trail. — source: https://www.weguide.health/alternatives/mydatahelps — checked 2026-11-10 - Data linkage and export: REST API and webhooks, HL7 and FHIR, and a two-way REDCap sync. — source: https://www.weguide.health/alternatives/fitabase — checked 2026-11-10 - Compliance and security: WeGuide states ISO 27001:2022 certification, HIPAA support (BAA on request), GDPR and FDA 21 CFR Part 11 support, and TGA Class I registration (ARTG 355337). The public page does not supply the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Published pricing and terms: Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [MyDataHelps (CareEvolution)](https://bestclinicaltrialsoftware.com/software/mydatahelps/): US academic cohorts that want participants sharing surveys, EHR and claims data in one self-service app - Participant app and retention: The MyDataHelps app with scheduled SMS, email or push notifications, education resources, returned results and eGift card rewards. — source: https://careevolution.com/mydatahelps/ — checked 2026-11-10 - Long-term follow-up and PRO instruments: A library of validated instruments and NIH common data elements, with custom delivery schedules. — source: https://careevolution.com/mydatahelps/ — checked 2026-11-10 - Remote enrolment and eConsent: Recruitment by shareable QR code or invitation, participant-facing eligibility checks, and automatically versioned screening surveys and eConsent. — source: https://careevolution.com/mydatahelps/fact-sheet-recruitment-and-econsent/ — checked 2026-11-10 - Data linkage and export: APIs and SDKs, a REDCap-integrated survey builder, and EHR and claims data from over 1.5 million providers, standardized to common code systems. — source: https://careevolution.com/mydatahelps/fact-sheet-ehr-emr/ — checked 2026-11-10 - Compliance and security: States HIPAA and FDA Part 11 compliance and NIST 800-53 controls assessed by a FedRAMP-accredited assessor, with an NIH Authority to Operate, but names no ISO 27001 or SOC 2 certification. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Published pricing and terms: A free Designer account to build and explore a study for as long as needed; no pricing basis, prices or terms for running a study are published. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - [OpenClinica](https://bestclinicaltrialsoftware.com/software/openclinica/): Registry teams that want published prices and browser-based participant forms on a standards-based EDC - Participant app and retention: A browser-based participant dashboard reached by secure link, with SMS and email reminders and an offline mode for forms; no native app and no participant messaging or education content. — source: https://www.openclinica.com/solutions/participate-electronic-patient-reported-outcomes-epro/ — checked 2026-11-10 - Long-term follow-up and PRO instruments: Visit-based and common events that can repeat, with calendaring to automate scheduling and notifications; no validated PRO instrument library is documented. — source: https://docs.openclinica.com/oc4/building-forms-and-studies/oc4-design-study/oc4-design-study-events/ — checked 2026-11-10 - Remote enrolment and eConsent: Public URL forms let participants self-register, each creating a new participant, and eConsent re-consent workflows trigger automatically after amendments. — source: https://docs.openclinica.com/oc4/participate/configure-forms-for-offline-mode-and-public-url/ — checked 2026-11-10 - Data linkage and export: REST API with clinical data import in CDISC ODM XML or JSON. — source: https://docs.openclinica.com/oc4/how-and-when-to-use-apis/oc4-clinicaldata-import-crf-data/ — checked 2026-11-10 - Compliance and security: Lists 21 CFR Part 11, HIPAA and GDPR compliance with SOC 2 Type II and ISO 27001 certification. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - Published pricing and terms: Publishes prices ($750 per month for the Launch plan, $3,000 per month per study for Pro) and a 30-day free trial. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - [Pulse Infoframe](https://bestclinicaltrialsoftware.com/software/pulse-infoframe/): Patient advocacy groups building a rare disease registry with real-world evidence services - Participant app and retention: A patient portal for onboarding and a communication hub for the registry community; no native app or automated reminders are described. — source: https://www.pulseinfoframe.com/evidence-central/ — checked 2026-11-10 - Long-term follow-up and PRO instruments: A repository of PRO measures and disease-specific data elements that can be deployed in longitudinal registries in over 25 diseases; follow-up scheduling and reminders are not described. — source: https://www.pulseinfoframe.com/ — checked 2026-11-10 - Remote enrolment and eConsent: In a follow-up registry case study, caregivers and clinicians enrolled through site-based or online pathways and completed eConsent; consent versioning is not described. — source: https://www.pulseinfoframe.com/platform-capabilities/ — checked 2026-11-10 - Data linkage and export: Ingests EHR, claims and genomic data mapped to OMOP, mCODE and CDISC, connects to content management services through an API, and allows SQL queries. — source: https://www.pulseinfoframe.com/healthie-20/ — checked 2026-11-10 - Compliance and security: States that healthie is GDPR, HIPAA and FDA 21 CFR Part 11 compliant, and shows a DEKRA ISO 27001 certification seal. — source: https://www.pulseinfoframe.com/evidence-central/ — checked 2026-11-10 - Published pricing and terms: Rare Central comes in three tiers (Starter, Accelerated and Advanced), with the scope of each described but no prices. — source: https://www.pulseinfoframe.com/rare-central/ — checked 2026-11-10 - [REDCap](https://bestclinicaltrialsoftware.com/software/redcap/): Academic and nonprofit registries whose institution already hosts REDCap - Participant app and retention: MyCap is a free native iOS and Android app with offline entry, due-day task alerts, in-app messaging and announcements; it cannot yet send reminders for incomplete tasks. — source: https://projectmycap.org/frequently-asked-questions-faqs/ — checked 2026-11-10 - Long-term follow-up and PRO instruments: A library of validated instruments including PROMIS and Neuro-QoL computerized adaptive tests, with automatic survey invitations for follow-up. — source: https://portal.redcap.yale.edu/more-information-about-redcap — checked 2026-11-10 - Remote enrolment and eConsent: e-Consent surveys can be opened from a public survey link or QR code, and each consent form has version control. — source: https://researchcalgary.atlassian.net/wiki/spaces/CCTSTRED/pages/3530620946/How+to+setup+and+use+eConsent — checked 2026-11-10 - Data linkage and export: REDCap pulls structured EHR data into projects through a FHIR web service (Clinical Data Interoperability Services), alongside the REDCap API; EHR access depends on the hosting institution. — source: https://project-redcap.org/software/ — checked 2026-11-10 - Compliance and security: REDCap can be installed in compliance with HIPAA and 21 CFR Part 11, but compliance depends on each hosting institution and there is no vendor certification. — source: https://project-redcap.org/software/ — checked 2026-11-10 - Published pricing and terms: The REDCap license is free for nonprofit consortium members, who host it themselves, and MyCap is free; for-profit teams must use paid hosting. — source: https://projectredcap.org/about/faq/ — checked 2026-11-10 - [Vibrent Health](https://bestclinicaltrialsoftware.com/software/vibrent/): Large population cohorts that need digital enrollment, eConsent and return of results at scale - Participant app and retention: Participant software for iOS, Android and web covering screening, eConsent, surveys and return of information, with SMS, email and push notification workflows. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - Long-term follow-up and PRO instruments: Drag-and-drop forms, ePRO and notification workflows, used for cohorts such as All of Us; no validated PRO library or follow-up scheduling detail is published. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - Remote enrolment and eConsent: Participants are screened and enrolled digitally and sign eConsent; consent versioning or re-consent is not described. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - Data linkage and export: Ingests EMR data, connects wearables, and imports and exports surveys and data with REDCap; no public API is documented. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - Compliance and security: Lists HIPAA, NIST, FISMA, SOC 1 and SOC 2 Type II and FedRAMP (moderate), and an FDA 21 CFR Part 11-validated system. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - Published pricing and terms: No prices published; products are sold a la carte on a SaaS pricing model. — source: https://info.vibrenthealth.com/dct — checked 2026-11-10 - [Best REDCap alternatives](https://bestclinicaltrialsoftware.com/best/redcap-alternatives/): Research teams choosing a new platform for study data collection or extending an existing REDCap setup. - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Studies that need ongoing participant engagement and remote data collection, with support to move from REDCap to WeGuide or keep REDCap connected - Participant app and study branding: Native iOS and Android participant apps with the organization’s branding, configured welcome screens and study features, and dedicated Apple and Google store listings under the organization’s name. — source: https://www.weguide.health/platform/white-labeling — checked 2026-11-12 - ePRO and eConsent depth: Scheduled ePRO with reminders plus eConsent with version control, reconsent and an audit trail. — source: https://www.weguide.health/alternatives/mydatahelps — checked 2026-11-10 - Works with REDCap: The Integration Engine connects to REDCap with configurable field mapping and two-way data exchange. WeGuide’s team helps plan, configure and test the connection, supporting data transfer during a move to WeGuide or continued use of both platforms. The transfer scope and setup depend on the study. — source: https://www.weguide.health/integration-engine — checked 2026-11-13 - Build it yourself: Coordinators build in the no-code Program Builder, but WeGuide's team activates languages, publishes apps and configures integrations. — source: https://www.weguide.health/platform/multi-language — checked 2026-11-10 - Compliance and security: WeGuide states ISO 27001:2022 certification, HIPAA support (BAA on request), GDPR and FDA 21 CFR Part 11 support, and TGA Class I registration (ARTG 355337). The public page does not supply the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Published pricing and terms: Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): Academic and medical device teams that want EDC, eCOA and eConsent in one platform - Participant app and study branding: Castor Connect native iOS and Android app; Castor-branded, with no own-brand option documented. — source: https://helpdesk.castoredc.com/hc/en-us/articles/27187047287325-Castor-Connect-ePRO-app — checked 2026-11-10 - ePRO and eConsent depth: Scheduled ePRO and eConsent with audit trails and re-consent, native to the platform. — source: https://www.castoredc.com/about-castor/ — checked 2026-11-10 - Works with REDCap: Imports CSV, Excel or CDISC ODM exports from other EDCs and has open APIs; no REDCap-specific importer documented. — source: https://www.castoredc.com/blog/medical-device-study-no-code-edc/ — checked 2026-11-10 - Build it yourself: No-code EDC builder, but eCOA studies are built and managed by Castor's services team. — source: https://www.castoredc.com/ecoa-epro-clinical-trials/ — checked 2026-11-10 - Compliance and security: Castor publishes its ISO/IEC 27001:2022 certificate, and its eCOA page states Part 11, Annex 11, HIPAA and GDPR support. — source: https://www.castoredc.com/wp-content/uploads/2025/08/ISO-27001-2022_Expiration-DEC-2026.pdf — checked 2026-11-10 - Published pricing and terms: No prices published; Castor describes flat-rate per-study licensing with no per-subject fees and quotes on request. — source: https://www.castoredc.com/why-castor/castor-vs-openclinica/ — checked 2026-11-10 - [Medrio](https://bestclinicaltrialsoftware.com/software/medrio/): Mid-size sponsors moving from REDCap to a commercial EDC with ePRO and eConsent - Participant app and study branding: Web-based ePRO on any device with reminders; no native app. — source: https://medrio.com/solutions/epro/ — checked 2026-11-10 - ePRO and eConsent depth: Scheduled ePRO with reminders plus eConsent with electronic signatures and version control. — source: https://medrio.com/solutions/econsent/ — checked 2026-11-10 - Works with REDCap: Public REST API (Medrio API Connect); no REDCap-specific importer documented. — source: https://connectapi.medrio.com/swagger/index.html — checked 2026-11-10 - Build it yourself: No-code, point-and-click builds that data managers run themselves. — source: https://medrio.com/blog/edc-study-build/ — checked 2026-11-10 - Compliance and security: Lists Part 11, Annex 11, GDPR, HIPAA, ISO 27001 and SOC 2. — source: https://medrio.com/data-safety-and-security/ — checked 2026-11-10 - Published pricing and terms: No prices published; Medrio describes its pricing as subscription-based. — source: https://medrio.com/blog/edc-study-build/ — checked 2026-11-10 - [MyDataHelps (CareEvolution)](https://bestclinicaltrialsoftware.com/software/mydatahelps/): Teams that want to reuse REDCap instruments in a mobile app they build themselves - Participant app and study branding: Participants normally use the shared MyDataHelps app. CareEvolution also documents a separate white-label All of Us app supporting enrollment, eConsent, ePRO and participant engagement; a custom deployment must be scoped. — source: https://careevolution.com/case-studies/facilitating-precision-medicine-research-through-the-all-of-us-research-program/ — checked 2026-11-12 - ePRO and eConsent depth: Scheduled surveys with push, SMS or email notifications plus eConsent with typed and drawn signatures configurable for Part 11. — source: https://support.mydatahelps.org/creating-econsent-enrollment-surveys — checked 2026-11-10 - Works with REDCap: Documented REDCap integration that imports instruments and sends responses back to REDCap. — source: https://support.mydatahelps.org/redcap-integration-overview — checked 2026-11-10 - Build it yourself: Self-service no-code Designer, free to start. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Compliance and security: States HIPAA and Part 11 compliance and NIST 800-53 controls assessed by a FedRAMP 3PAO with an NIH Authority to Operate, but names no ISO 27001 or SOC 2 certification. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Published pricing and terms: A free Designer account to build and explore a study; paid pricing for running studies is not published. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - [OpenClinica](https://bestclinicaltrialsoftware.com/software/openclinica/): Teams moving off REDCap that want a validated EDC with published prices - Participant app and study branding: Browser-based participant dashboard with SMS and email reminders; no native app. — source: https://www.openclinica.com/solutions/participate-electronic-patient-reported-outcomes-epro/ — checked 2026-11-10 - ePRO and eConsent depth: Scheduled ePRO with reminders plus eConsent with e-signatures and re-consent workflows. — source: https://www.openclinica.com/solutions/econsent/ — checked 2026-11-10 - Works with REDCap: Clinical data import API in CDISC ODM XML or JSON; no REDCap-specific importer documented. — source: https://docs.openclinica.com/oc4/how-and-when-to-use-apis/oc4-clinicaldata-import-crf-data/ — checked 2026-11-10 - Build it yourself: Drag-and-drop study designer for self-service builds, with an optional free managed build. — source: https://www.openclinica.com/edc-with-free-study-build/ — checked 2026-11-10 - Compliance and security: Lists 21 CFR Part 11, HIPAA and GDPR compliance with SOC 2 Type II and ISO 27001 certification. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - Published pricing and terms: Publishes prices ($750 per month for the Launch plan, $3,000 per month per study for Pro) and a 30-day free trial. — source: https://www.openclinica.com/pricing/ — checked 2026-11-10 - [Qualtrics](https://bestclinicaltrialsoftware.com/software/qualtrics/): Survey-only studies that need strong security credentials and published prices - Participant app and study branding: Participants answer through survey links; there is no participant app. — source: https://www.qualtrics.com/support/survey-platform/managing-your-account/trial-accounts/ — checked 2026-11-10 - ePRO and eConsent depth: Surveys plus a drawn-signature question add-on; no Part 11 eConsent workflow or participant schedule is documented. — source: https://www.qualtrics.com/support/survey-platform/survey-module/editing-questions/question-types-guide/specialty-questions/signature/ — checked 2026-11-10 - Works with REDCap: Paid plans include an API and data import; no REDCap-specific importer documented. — source: https://www.qualtrics.com/support/survey-platform/managing-your-account/trial-accounts/ — checked 2026-11-10 - Build it yourself: Self-service survey builder. — source: https://www.qualtrics.com/support/survey-platform/managing-your-account/trial-accounts/ — checked 2026-11-10 - Compliance and security: Holds ISO 27001, SOC 2 Type II, HITRUST and FedRAMP, but no public 21 CFR Part 11 statement was found. — source: https://www.qualtrics.com/security-statement/ — checked 2026-11-10 - Published pricing and terms: Publishes a free account and Strategic Research at $420 per month ($5,040 a year) for up to 1,000 responses. — source: https://www.qualtrics.com/buy-online/ — checked 2026-11-10 - [Viedoc](https://bestclinicaltrialsoftware.com/software/viedoc/): Teams moving to a sponsor-grade EDC with ePRO and eConsent - Participant app and study branding: Viedoc Me web app on any device with email and SMS reminders; no native app. — source: https://www.viedoc.com/products/viedoc-me — checked 2026-11-10 - ePRO and eConsent depth: Scheduled ePRO with reminders plus Part 11 eSignature for informed consent in Viedoc Me. — source: https://www.viedoc.com/products/esignature — checked 2026-11-10 - Works with REDCap: REST API for integrations; no REDCap-specific importer documented. — source: https://www.viedoc.com/products/edc-software — checked 2026-11-10 - Build it yourself: Self-service designer; teams configure studies without raising a support ticket. — source: https://www.viedoc.com/products/edc-software — checked 2026-11-10 - Compliance and security: ISO 27001:2022-certified ISMS and a SOC 2 Type 2 report, with stated Part 11, HIPAA and GDPR compliance. — source: https://www.viedoc.com/security-and-compliance — checked 2026-11-10 - Published pricing and terms: Publishes a per-study, per-module licensing model with unlimited users and nonprofit and academic pricing, but no prices. — source: https://www.viedoc.com/pricing — checked 2026-11-10 - [Best RTSM and IRT systems](https://bestclinicaltrialsoftware.com/best/rtsm-irt/): Sponsors and CROs choosing a randomization and trial supply management (RTSM, also called IRT) system for interventional trials. - [Prancer RTSM](https://bestclinicaltrialsoftware.com/software/4g-clinical/): Sponsors and CROs with complex dosing or adaptive designs who want an RTSM specialist with supply forecasting - Randomization and blinding: 4G names stratification, cohort-specific logic, variable blocks and minimization, with versioned logic that protects blinding and handles re-randomization. — source: https://www.4gclinical.com/services-delivery — checked 2026-11-10 - Trial supply management: Prancer handles dispensing and resupply with buffer-to-predictive forecasting and 4C Supply scenario modeling; direct-to-patient shipping was added in April 2020 (4G blog). — source: https://www.4gclinical.com/technology — checked 2026-11-10 - Study build speed and mid-study changes: 4G says its NLP-based build takes under four weeks, with specification sign-off to go-live in as little as 13 calendar days, and changes made without impacting study progress. — source: https://www.4gclinical.com/hubfs/White_Paper_2026/Faster_Study_Startup_WP_US.pdf — checked 2026-11-10 - Integrations and platform: 4G documents connections to EDC, CTMS, depot and logistics systems and data warehouses, but has no EDC or eCOA of its own and we found no public API reference. — source: https://www.4gclinical.com/technology — checked 2026-11-10 - Compliance and security evidence: The trust center reports a SOC 2 Type 2 report for the 12 months ending 31 August 2026 and states compliance with 21 CFR Part 11 and EU Annex 11. — source: https://www.4gclinical.com/trust-center — checked 2026-11-10 - Track record: 4G says it has evolved to support more than a thousand studies worldwide. — source: https://www.4gclinical.com/trial-trends/how-innovation-and-trust-took-root — checked 2026-11-10 - [Almac IXRS 3](https://bestclinicaltrialsoftware.com/software/almac/): Sponsors who also use Almac for clinical packaging and distribution and want IRT, forecasting and logistics from one group - Randomization and blinding: Almac describes simple to complex adaptive designs with enrollment caps, cohorts and blinding protection, but does not name allocation methods. — source: https://www.almacgroup.com/clinical-technologies/ixrs3-interactive-response-technology/ — checked 2026-11-10 - Trial supply management: IXRS 3 documents resupply strategy, expiry and depot management, Almac's SupplyWise integrates demand forecasting with the IRT, and an Almac datasheet (Clinical Leader, August 2025) describes direct-to-patient workflows. — source: https://www.almacgroup.com/clinical-services/supply-chain-solutions/forecasting-inventory — checked 2026-11-10 - Study build speed and mid-study changes: Almac describes a controlled-agile build with visual requirements tools, but publishes no build timeline or mid-study change process. — source: https://www.almacgroup.com/clinical-technologies/ixrs3-interactive-response-technology/ — checked 2026-11-10 - Integrations and platform: Almac lists pre-built connectors and REST, SOAP and secure file integrations with EDC, CTMS, clinical supplies and central labs, but has no EDC or eCOA of its own. — source: https://www.almacgroup.com/clinical-technologies/blogs/interactive-responsive-technology-data-integration — checked 2026-11-10 - Compliance and security evidence: Almac states its IXRS University training module is validated and 21 CFR Part 11 compliant; we found no named ISO 27001 or SOC 2 attestation for Clinical Technologies. — source: https://www.almacgroup.com/media/clinical-technologies/almac-ixrs-boosters-fact-sheet-2.pdf — checked 2026-11-10 - Track record: Almac's media kit reports 2,000 clinical trials and over 2 million patients on IXRS, in more than 85 countries (undated kit). — source: https://www3.almacgroup.com/hubfs/Almac-Overview-Media-and-Press-Release-Kit.pdf — checked 2026-11-10 - [Endpoint Clinical RTSM](https://bestclinicaltrialsoftware.com/software/endpoint-clinical/): Sponsors who want an RTSM specialist with self-service study changes and central pharmacy workflows - Randomization and blinding: Endpoint cites complex protocols, dosing strategies, adaptive designs and patient rollover, but its product pages do not name specific allocation methods. — source: https://www.endpointclinical.com/ — checked 2026-11-10 - Trial supply management: Elosity adds direct-to-patient delivery, site-to-site shipments, central pharmacy workflows and pooling, and Endpoint's Bluefin product provides AI-driven supply forecasting. — source: https://www.endpointclinical.com/solutions/elosity/ — checked 2026-11-10 - Study build speed and mid-study changes: Elosity claims a 2-6 week study setup and version-tracked quick changes without interrupting live studies; PULSE offers 20+ self-service modules. — source: https://www.endpointclinical.com/solutions/elosity/ — checked 2026-11-10 - Integrations and platform: Endpoint describes pre-built, API-based integrations with EDC, eCOA, eConsent and CTMS, but names no specific systems and has no EDC or eCOA of its own. — source: https://www.endpointclinical.com/faq/ — checked 2026-11-10 - Compliance and security evidence: Endpoint holds a SOC 2 Type II attestation (Prescient Assurance); we found no product-specific Part 11 or Annex 11 statement beyond a general FAQ. — source: https://www.endpointclinical.com/privacy — checked 2026-11-10 - Track record: Endpoint reports 2,000+ studies, 1M+ patients and 90+ countries. — source: https://www.endpointclinical.com/ — checked 2026-11-10 - [Medidata RTSM](https://bestclinicaltrialsoftware.com/software/medidata/): Sponsors already on Rave EDC who want randomization and supply in the same system - Randomization and blinding: A Medidata fact sheet lists pre-validated permuted block and dynamic allocation, stratification, cohort management, titration and a randomization simulator (fact sheet dated May 2019). — source: https://www.medidata.com/wp-content/uploads/2019/05/Customer-Facing-Fact-Sheet-Rave-RTSM-May-19.pdf — checked 2026-11-10 - Trial supply management: The current fact sheet documents buffer and predictive supply schemes, forecasting that simulates future patient needs, direct-to-patient shipments and drug pooling across studies. — source: https://www.medidata.com/wp-content/uploads/2024/07/RTSM-Fact-Sheet-May-24.pdf — checked 2026-11-10 - Study build speed and mid-study changes: Medidata states a 2-3 week study build, and Edit Live Design allows post-go-live changes for protocol amendments (the 2024 fact sheet adds 'little to no downtime'). — source: https://www.medidata.com/wp-content/uploads/2021/10/RTSM-Fact-Sheet-210923.pdf — checked 2026-11-10 - Integrations and platform: RTSM is unified with Rave EDC on the Medidata Platform and uses a pre-validated two-way integration with large depot vendors. — source: https://www.medidata.com/wp-content/uploads/2024/07/RTSM-Fact-Sheet-May-24.pdf — checked 2026-11-10 - Compliance and security evidence: Medidata lists an ISO 27001:2022 certificate and a SOC 2+ Type II audit, and says its position statements cover 21 CFR Part 11 and EU Annex 11 (the statements sit behind a customer login). — source: https://www.medidata.com/en/trust-and-transparency/ — checked 2026-11-10 - Track record: The RTSM page cites 124 countries supported and about 16,000 patients a month. — source: https://www.medidata.com/en/data-experience/rtsm/ — checked 2026-11-10 - [Signant SmartSignals RTSM](https://bestclinicaltrialsoftware.com/software/signant/): Sponsors who want RTSM, supply forecasting and eCOA from one vendor - Randomization and blinding: Signant mentions emergency unblinding and support for any protocol design or randomization scheme, but does not name allocation methods. — source: https://signanthealth.com/solutions/rtsm/randomization-trial-supply-management — checked 2026-11-10 - Trial supply management: Signant documents direct-to-patient dispensing, cross-study pooling, shelf-life optimization and a Forecasting and Planning module in SmartSignals Supplies. — source: https://signanthealth.com/hubfs/Marketing%20Assets/Brochures/Brochure%20-%20Signant%20SmartSignals%20RTSM.pdf — checked 2026-11-10 - Study build speed and mid-study changes: Signant states new builds in as little as three weeks from requirements sign-off to UAT and AI-assisted impact assessment for amendments, but does not claim changes without downtime. — source: https://signanthealth.com/hubfs/Marketing%20Assets/Brochures/Brochure%20-%20Signant%20SmartSignals%20RTSM.pdf — checked 2026-11-10 - Integrations and platform: The RTSM connects to Signant's own eCOA and supplies software, third-party EDC and manufacturing systems, and offers RTSM APIs for near real-time data. — source: https://signanthealth.com/solutions/rtsm/randomization-trial-supply-management — checked 2026-11-10 - Compliance and security evidence: Signant states that its SmartSignals Supplies inventory transaction history is 21 CFR Part 11 compliant; we found no named ISO 27001 or SOC 2 attestation. — source: https://signanthealth.com/solutions/supply-chain-software/gxp-inventory — checked 2026-11-10 - Track record: A March 2026 Signant brochure reports 2,000+ RTSM studies in 90+ countries and 600+ sponsors and CROs as customers. — source: https://signanthealth.com/hubfs/Marketing%20Assets/Brochures/Brochure%20-%20Signant%20SmartSignals%20RTSM.pdf — checked 2026-11-10 - [Suvoda RTSM](https://bestclinicaltrialsoftware.com/software/suvoda/): Oncology, CNS and rare disease sponsors who want IRT alongside eCOA, eConsent and patient payments on one platform - Randomization and blinding: Suvoda lists adaptive randomization, stratification, cohort and dose management and blinding management, but its public pages do not name minimization or dynamic allocation. — source: https://www.suvoda.com/insights/blog/rtsm-irt-faq-a-guide-to-interactive-response-technology — checked 2026-11-10 - Trial supply management: The RTSM page lists drug supply forecasting, direct-to-patient shipping, temperature excursion management, and accountability, returns and destruction. — source: https://www.suvoda.com/rtsm-irt-clinical-trial — checked 2026-11-10 - Study build speed and mid-study changes: Suvoda states kickoff to UAT in as little as two weeks (footnoted as preliminary testing), and permissioned users can make common post-go-live changes without a change order. — source: https://www.suvoda.com/rtsm-irt-clinical-trial — checked 2026-11-10 - Integrations and platform: Suvoda reports integrations with more than 100 eClinical systems, standardized pre-built API integrations with top EDC providers and a REST API. — source: https://www.suvoda.com/systems-integration — checked 2026-11-10 - Compliance and security evidence: Suvoda says its RTSM adheres to 21 CFR Part 11 and that it maintains SOC 2 Type 2 compliance; its certifications page confirms an annual SOC 2 Type 2 audit for RTSM. — source: https://www.suvoda.com/insights/blog/rtsm-irt-faq-a-guide-to-interactive-response-technology — checked 2026-11-10 - Track record: Suvoda reports 6,000+ trials and 115+ countries supported. — source: https://www.suvoda.com/ — checked 2026-11-10 - [Veeva RTSM](https://bestclinicaltrialsoftware.com/software/veeva/): Sponsors standardizing on the Veeva Clinical Platform who want RTSM connected to Veeva EDC, eCOA and CTMS - Randomization and blinding: Veeva lists static, stratified, dynamic/minimization, forced and adaptive schemas, re-randomization, capping and sentinel dosing. — source: https://www.veeva.com/eu/resources/veeva-rtsm-product-brief/ — checked 2026-11-10 - Trial supply management: Veeva documents threshold, predictive and just-in-time resupply with expiry buffers and accountability, but no direct-to-patient shipping or separate forecasting tool. — source: https://www.veeva.com/resources/veeva-rtsm-resupply-feature-brief/ — checked 2026-11-10 - Study build speed and mid-study changes: Authorized users can switch on cohorts and change limits mid-study, and Veeva says design-change amendments often take days rather than weeks; no initial build timeline is published. — source: https://www.veeva.com/eu/resources/veeva-rtsm-product-brief/ — checked 2026-11-10 - Integrations and platform: Productized connections send data to Veeva EDC, eCOA and DQS and take site data from Veeva CTMS, and the brief cites third-party EDC and shipping-provider connections. — source: https://www.veeva.com/products/veeva-rtsm/ — checked 2026-11-10 - Compliance and security evidence: Veeva's trust page lists ISO 27001 audits and a SOC 2 Type II report, but we found no RTSM-specific Part 11 or Annex 11 statement. — source: https://www.veeva.com/trust/ — checked 2026-11-10 - Track record: Veeva reports that a top-20 biopharma selected Veeva RTSM as its enterprise standard (fiscal 2026); no total study or customer count for RTSM is published. — source: https://ir.veeva.com/news/news-details/2026/Veeva-Announces-Fourth-Quarter-and-Fiscal-Year-2026-Results/default.aspx — checked 2026-11-10 - [YPrime IRT](https://bestclinicaltrialsoftware.com/software/yprime/): Sponsors with complex randomization schemes, including minimization, who may also use YPrime eCOA - Randomization and blinding: YPrime names permuted block and stratified randomization, dynamic allocation and minimization (Pocock and Simon), stratum caps and conditional re-randomization. — source: https://www.yprime.com/irt/ — checked 2026-11-10 - Trial supply management: The IRT page covers inventory, orders, resupply, kit replacement and depot rules, but does not describe supply forecasting or direct-to-patient shipping. — source: https://www.yprime.com/irt/ — checked 2026-11-10 - Study build speed and mid-study changes: YPrime cites build to go-live in under four weeks for an early-phase oncology trial, about a week for the simplest designs, and self-service routine changes that take effect immediately. — source: https://www.yprime.com/irt/ — checked 2026-11-10 - Integrations and platform: YPrime documents integrations with EDC, eCOA, eConsent, CTMS, labs, distribution systems and data lakes, and runs its own eCOA. — source: https://www.yprime.com/irt/ — checked 2026-11-10 - Compliance and security evidence: YPrime's trust page lists 21 CFR Part 11, GDPR and HIPAA compliance, but we found no ISO 27001 or SOC 2 attestation. — source: https://www.yprime.com/trust-with-certainty/ — checked 2026-11-10 - Track record: YPrime reports 55,000+ sites and 300,000+ patients supported and 20+ years of IRT work, but publishes no study count. — source: https://www.yprime.com/irt/ — checked 2026-11-10 - [Best software for wearable data collection in clinical trials](https://bestclinicaltrialsoftware.com/best/wearable-data-collection/): Studies that collect data from participants' own consumer wearables (Apple Health, Health Connect, Fitbit, Garmin, Oura and similar) alongside ePRO in the same participant app. - [Ametris (formerly ActiGraph)](https://bestclinicaltrialsoftware.com/software/ametris/): Sponsor trials that need actigraphy endpoints from research-grade devices - Consumer wearable coverage: Supports its own ActiGraph devices and validated clinical sensors; no consumer wearable platform integration is documented. — source: https://ametris.com/digital-health-technology — checked 2026-11-10 - Data depth and granularity: High-resolution raw sub-second accelerometry processed in the CentrePoint cloud and available through its API. — source: https://ametris.com/centrepoint — checked 2026-11-10 - ePRO in the same app: The Ametris Connect app supports ePRO, eConsent and virtual visits alongside device uploads. — source: https://ametris.com/digital-health-technology — checked 2026-11-10 - Adherence and sync monitoring: Near real-time wear-adherence monitoring with monthly reports, and an app notification system to improve adherence. — source: https://ametris.com/centrepoint — checked 2026-11-10 - Compliance and security: States Part 11, HIPAA and GDPR compliance with 510(k) clearance and CE mark; no ISO 27001 or SOC 2 certification of its own is named. — source: https://ametris.com/digital-health-technology — checked 2026-11-10 - Published pricing and terms: No pricing model, prices or contract terms published. — source: https://ametris.com/digital-health-technology — checked 2026-11-10 - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Studies that need ongoing participant engagement alongside wearable data, questionnaires, consent and follow-up in one study app - Consumer wearable coverage: Garmin is native; Apple Health and Health Connect are supported data routes, and Fitbit Air support is listed. Other makers’ data depends on the metrics their apps share with the phone health store. Confirm the proposed model and route. — source: https://www.weguide.health/tools/research-wearable-comparison — checked 2026-11-12 - Data depth and granularity: Raw accelerometer and gyroscope data at 25 Hz are documented for supported Garmin models. Phone health-store data and Fitbit Air support do not imply the same raw-sensor access. — source: https://www.weguide.health/tools/research-wearable-comparison — checked 2026-11-12 - ePRO in the same app: eConsent with version control and ePRO from a validated library in the same app that syncs the wearable. — source: https://www.weguide.health/alternatives/fitabase — checked 2026-11-10 - Adherence and sync monitoring: Wear and sync reminders through push notifications and in-app messaging, and live adherence monitoring; a sync-status dashboard is not described publicly. — source: https://www.weguide.health/alternatives/fitabase — checked 2026-11-10 - Compliance and security: WeGuide states ISO 27001:2022 certification, HIPAA support (BAA on request), GDPR and FDA 21 CFR Part 11 support, and TGA Class I registration (ARTG 355337). The public page does not supply the certificate or an audit report. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - Published pricing and terms: Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published. — source: https://www.weguide.health/alternatives/yprime — checked 2026-11-12 - [Datacubed Health](https://bestclinicaltrialsoftware.com/software/datacubed/): Sponsor eCOA studies that add phone-based health data to questionnaires - Consumer wearable coverage: Apple Health and Google Fit plus other connected sensors and medical devices. — source: https://www.datacubed.com/product-suite/connected-sensors-and-integrations/ — checked 2026-11-10 - Data depth and granularity: Wearable data granularity is not documented on its public pages. — source: https://www.datacubed.com/product-suite/connected-sensors-and-integrations/ — checked 2026-11-10 - ePRO in the same app: ePRO, eCOA and eConsent in the same participant app. — source: https://www.datacubed.com/product-suite/ — checked 2026-11-10 - Adherence and sync monitoring: Real-time dashboards for compliance, retention and device usage; automated non-sync alerts are not described. — source: https://www.datacubed.com/product-suite/ — checked 2026-11-10 - Compliance and security: States Part 11, HIPAA and GDPR compliance; no ISO 27001 or SOC 2 certification found on its public pages. — source: https://www.datacubed.com/delivery-success/fit-for-purpose-architecture/ — checked 2026-11-10 - Published pricing and terms: No pricing model, prices or contract terms published. — source: https://www.datacubed.com/ — checked 2026-11-10 - [Fitabase](https://bestclinicaltrialsoftware.com/software/fitabase/): Academic teams collecting Fitbit or Garmin data who need close sync and battery monitoring - Consumer wearable coverage: Fitbit (through the Google Health API) and Garmin devices only. — source: https://www.fitabase.com/resources/faq/ — checked 2026-11-10 - Data depth and granularity: Heart rate every 3 to 15 seconds, 30-second sleep stages and minute-level activity; raw accelerometer data is not documented. — source: https://www.fitabase.com/resources/knowledge-base/learn-about-fitbit-data/data-resolutions/ — checked 2026-11-10 - ePRO in the same app: The Fitabase Engage app delivers surveys, EMA and just-in-time prompts; no eConsent. — source: https://www.fitabase.com/engage/mobile/ — checked 2026-11-10 - Adherence and sync monitoring: Dashboards of sync times, battery and connection status, plus automated SMS alerts on sync lapses and charging (premium add-on). — source: https://www.fitabase.com/how-it-works/pricing/ — checked 2026-11-10 - Compliance and security: Public security page covers Azure hosting, SSL and access logging but makes no Part 11, HIPAA or GDPR statement. — source: https://www.fitabase.com/resources/knowledge-base/working-with-the-irb/data-security-privacy/ — checked 2026-11-10 - Published pricing and terms: Custom quote per study; the pricing page lists what the core platform includes and which items are premium add-ons, without prices. — source: https://www.fitabase.com/how-it-works/pricing/ — checked 2026-11-10 - [Medable](https://bestclinicaltrialsoftware.com/software/medable/): Large sponsor-led decentralized trials that need eCOA with connected medical devices - Consumer wearable coverage: Public sources name a Withings partnership and Apple HealthKit use, but no list of supported consumer platforms. — source: https://www.medable.com/newsroom/medable-announces-partnership-with-withings-health-solutions-to-integrate-connected-health-devices-in-decentralized-clinical-trials — checked 2026-11-10 - Data depth and granularity: Wearable data granularity is not documented on its public pages. — source: https://www.medable.com/platform/ecoa-epro — checked 2026-11-10 - ePRO in the same app: eCOA, ePRO diaries and eConsent in the participant app. — source: https://www.medable.com/resources/faq — checked 2026-11-10 - Adherence and sync monitoring: Real-time compliance and participation dashboard with notifications and reminders; device-sync alerts are not described. — source: https://www.medable.com/resources/faq — checked 2026-11-10 - Compliance and security: States its products conform to Part 11, HIPAA and GDPR; no ISO 27001 or SOC 2 certification found on its public pages. — source: https://www.medable.com/resources/faq — checked 2026-11-10 - Published pricing and terms: Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount. — source: https://www.medable.com/platform/overview — checked 2026-11-10 - [MyDataHelps (CareEvolution)](https://bestclinicaltrialsoftware.com/software/mydatahelps/): US studies that want the broadest consumer device and EHR coverage in a self-service tool - Consumer wearable coverage: Apple Health, Health Connect, Google Health (including Fitbit), Garmin, Oura and Omron. — source: https://support.mydatahelps.org/sensor-data-services — checked 2026-11-10 - Data depth and granularity: Device Data API v2 supports granular sleep and heart-rate data and Garmin 15-minute epochs; raw sensor streams are not documented. — source: https://developer.mydatahelps.org/concepts/data.html — checked 2026-11-10 - ePRO in the same app: eConsent, surveys and active tasks in the same iOS and Android app that collects device data. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Adherence and sync monitoring: Targeted push, SMS or email nudges based on adherence and device usage; a dedicated sync-completeness dashboard is not described. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Compliance and security: States HIPAA and Part 11 compliance and NIST 800-53 controls assessed by a FedRAMP 3PAO with an NIH Authority to Operate, but names no ISO 27001 or SOC 2 certification. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 - Published pricing and terms: A free Designer account to build and explore a study; paid pricing for running studies is not published. — source: https://careevolution.com/mydatahelps/faqs/ — checked 2026-11-10 ## Comparisons Choose a category before comparing two products. Pair pages reuse only that category’s sourced feature notes; there are no overall ratings or winners. - [Compare CTMS products](https://bestclinicaltrialsoftware.com/compare/ctms-software/): 7 products, 6 shared feature topics. - [Compare eCOA products](https://bestclinicaltrialsoftware.com/compare/ecoa-platforms/): 8 products, 6 shared feature topics. - [Compare eConsent products](https://bestclinicaltrialsoftware.com/compare/econsent-software/): 8 products, 6 shared feature topics. - [Compare EDC products](https://bestclinicaltrialsoftware.com/compare/edc-systems/): 9 products, 6 shared feature topics. - [Compare ePRO products](https://bestclinicaltrialsoftware.com/compare/epro-software/): 8 products, 6 shared feature topics. - [Compare eTMF products](https://bestclinicaltrialsoftware.com/compare/etmf-software/): 8 products, 6 shared feature topics. - [Compare Registries products](https://bestclinicaltrialsoftware.com/compare/patient-registry-software/): 8 products, 6 shared feature topics. - [Compare Alternatives products](https://bestclinicaltrialsoftware.com/compare/redcap-alternatives/): 7 products, 6 shared feature topics. - [Compare RTSM / IRT products](https://bestclinicaltrialsoftware.com/compare/rtsm-irt/): 8 products, 6 shared feature topics. - [Compare Wearables products](https://bestclinicaltrialsoftware.com/compare/wearable-data-collection/): 6 products, 6 shared feature topics. - [Medidata Rave EDC vs Veeva Vault EDC for sponsors and CROs (2026)](https://bestclinicaltrialsoftware.com/compare/medidata-vs-veeva/) ## Software profiles - [4G Clinical](https://bestclinicaltrialsoftware.com/software/4g-clinical/): RTSM / IRT - [Advarra Clinical Conductor](https://bestclinicaltrialsoftware.com/software/advarra-clinical-conductor/): Site CTMS - [Advarra OnCore](https://bestclinicaltrialsoftware.com/software/advarra-oncore/): Site CTMS - [Almac Clinical Technologies](https://bestclinicaltrialsoftware.com/software/almac/): RTSM / IRT - [Ametris (formerly ActiGraph)](https://bestclinicaltrialsoftware.com/software/ametris/): Research-grade wearables and digital endpoints - [ArborMetrix](https://bestclinicaltrialsoftware.com/software/arbormetrix/): Clinical registry and analytics platform - [Castor](https://bestclinicaltrialsoftware.com/software/castor/): EDC with eCOA and eConsent - [Clario](https://bestclinicaltrialsoftware.com/software/clario/): eCOA - [CRIO](https://bestclinicaltrialsoftware.com/software/crio/): Site CTMS - [Datacubed Health](https://bestclinicaltrialsoftware.com/software/datacubed/): eCOA and ePRO - [Egnyte](https://bestclinicaltrialsoftware.com/software/egnyte/): eTMF - [Endpoint Clinical](https://bestclinicaltrialsoftware.com/software/endpoint-clinical/): RTSM / IRT - [Ennov](https://bestclinicaltrialsoftware.com/software/ennov/): eTMF - [Fitabase](https://bestclinicaltrialsoftware.com/software/fitabase/): Wearable data platform - [Florence Healthcare](https://bestclinicaltrialsoftware.com/software/florence/): eConsent, eTMF - [Kayentis](https://bestclinicaltrialsoftware.com/software/kayentis/): eCOA - [Medable](https://bestclinicaltrialsoftware.com/software/medable/): Decentralized trial platform with eCOA - [Medidata](https://bestclinicaltrialsoftware.com/software/medidata/): eCOA, eConsent, EDC, RTSM / IRT, eTMF - [Medrio](https://bestclinicaltrialsoftware.com/software/medrio/): EDC with ePRO and eConsent - [Montrium](https://bestclinicaltrialsoftware.com/software/montrium/): eTMF - [MyDataHelps (CareEvolution)](https://bestclinicaltrialsoftware.com/software/mydatahelps/): Digital research platform - [OpenClinica](https://bestclinicaltrialsoftware.com/software/openclinica/): EDC with ePRO and eConsent - [Oracle Clinical One](https://bestclinicaltrialsoftware.com/software/oracle/): EDC - [Phlexglobal](https://bestclinicaltrialsoftware.com/software/phlexglobal/): eTMF - [Pulse Infoframe](https://bestclinicaltrialsoftware.com/software/pulse-infoframe/): Patient registry and real-world evidence platform - [Qualtrics](https://bestclinicaltrialsoftware.com/software/qualtrics/): Survey platform - [RealTime-CTMS](https://bestclinicaltrialsoftware.com/software/realtime/): Site CTMS - [REDCap](https://bestclinicaltrialsoftware.com/software/redcap/): Academic EDC and surveys - [Signant Health](https://bestclinicaltrialsoftware.com/software/signant/): eCOA, eConsent, RTSM / IRT - [Suvoda](https://bestclinicaltrialsoftware.com/software/suvoda/): RTSM / IRT - [Trial Interactive](https://bestclinicaltrialsoftware.com/software/trial-interactive/): eTMF - [Veeva SiteVault](https://bestclinicaltrialsoftware.com/software/veeva-sitevault/): eConsent, Site CTMS - [Veeva Vault](https://bestclinicaltrialsoftware.com/software/veeva/): EDC, RTSM / IRT, eTMF - [Vibrent Health](https://bestclinicaltrialsoftware.com/software/vibrent/): Digital research platform for population cohorts - [Viedoc](https://bestclinicaltrialsoftware.com/software/viedoc/): EDC with ePRO and eConsent - [WCG Velos eResearch](https://bestclinicaltrialsoftware.com/software/wcg-velos/): Site CTMS - [WeGuide](https://bestclinicaltrialsoftware.com/software/weguide/): Clinical trial data collection and participant engagement - [YPrime](https://bestclinicaltrialsoftware.com/software/yprime/): eCOA, RTSM / IRT ## Comparison method - [How we compare](https://bestclinicaltrialsoftware.com/methodology/): feature statements, public sources, checked dates and missing evidence. - [Corrections](https://bestclinicaltrialsoftware.com/corrections/) - [About](https://bestclinicaltrialsoftware.com/about/)